Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
ý
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2017
OR
o
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-137533
GCP Applied Technologies Inc.
Delaware
(State of Incorporation)
 
47-3936076
(I.R.S. Employer Identification No.)
62 Whittemore Avenue, Cambridge, Massachusetts 02140-1623
(617) 876-1400
(Address and phone number of principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý     No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  ý     No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  o
 
Accelerated filer  o
 
Non-accelerated filer  ý
  (Do not check if a
smaller reporting company)
 
Smaller reporting company  o
 
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o     No  ý
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
Class
 
Outstanding at May 2, 2017
Common Stock, $0.01 par value per share
 
71,465,608 shares
 



Table of Contents

TABLE OF CONTENTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_______________________________________________________________________________

2


Table of Contents

Presentation of Information
Unless the context requires otherwise, references to "GCP Applied Technologies Inc.", "GCP", "we", "us", "our" and "the Company" refer to GCP Applied Technologies Inc., and its consolidated subsidiaries for periods subsequent to its separation from W.R. Grace & Co. on February 3, 2016. For periods prior to February 3, 2016, these terms refer to the combined historical business and operations of W.R. Grace & Co.’s construction products and packaging technologies businesses as they were historically managed as part of W.R. Grace & Co. Unless the context requires otherwise, references to "Grace" refer to W.R. Grace & Co., and its consolidated subsidiaries, which is the Company’s former parent company. References in this Quarterly Report on Form 10-Q to the "Separation" refer to the legal separation and transfer of Grace’s construction products and packaging technologies businesses to the Company through a dividend distribution of all of the then-outstanding common stock of GCP to Grace shareholders on February 3, 2016.
Forward-Looking Statements
This document contains, and our other public communications may contain, forward-looking statements, that is, information related to future, not past, events. Such statements generally include the words "believes," "plans," "intends," "targets," "will," "expects," "suggests," "anticipates," "outlook," "continues" or similar expressions. Forward-looking statements include, without limitation, expected financial positions; results of operations; cash flows; financing plans; business strategy; operating plans; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost reduction initiatives, plans and objectives; and markets for securities. Like other businesses, we are subject to risks and uncertainties that could cause our actual results to differ materially from our projections or that could cause other forward-looking statements to prove incorrect. Factors that could cause actual events to materially differ from those contained in the forward-looking statements include, without limitation: risks related to foreign operations, especially in emerging regions; the cost and availability of raw materials and energy; the effectiveness of GCP's research and development and growth investments; acquisitions and divestitures of assets and gains and losses from dispositions; developments affecting GCP’s outstanding indebtedness; developments affecting GCP's funded and unfunded pension obligations; GCP's legal and environmental proceedings; uncertainties related to the Company’s ability to realize the anticipated benefits of the separation transaction; the inability to establish or maintain certain business relationships and relationships with customers and suppliers or the inability to retain key personnel; costs of compliance with environmental regulation, and those factors set forth in our most recent Annual Report on Form 10-K, this Quarterly Report on Form 10-Q and Current Reports on Form 8-K, which have been filed with the Securities and Exchange Commission ("SEC") and are available on the Internet at www.sec.gov. Our reported results should not be considered as an indication of our future performance. Readers are cautioned not to place undue reliance on our projections and forward-looking statements, which speak only as of the date thereof. We undertake no obligation to publicly release any revisions to the projections and forward-looking statements contained in this document, or to update them to reflect events or circumstances occurring after the date of this document.


3


Table of Contents

PART I. FINANCIAL INFORMATION
Item 1.    Financial Statements
GCP Applied Technologies Inc.
Consolidated Statements of Operations (unaudited)
 
Three Months Ended March 31,
(In millions, except per share amounts)
2017
 
2016
Net sales
$
225.3

 
$
237.7

Cost of goods sold
140.0

 
144.5

Gross profit
85.3

 
93.2

Selling, general and administrative expenses
72.8

 
63.4

Research and development expenses
4.8

 
4.1

Interest expense and related financing costs
17.0

 
12.5

Repositioning expenses
2.0

 
4.3

Restructuring expenses
1.1

 
0.9

Other income (expense), net
1.0

 
(0.1
)
Total costs and expenses
98.7

 
85.1

(Loss) income from continuing operations before income taxes
(13.4
)
 
8.1

Provision for income taxes
(11.6
)

(1.7
)
(Loss) income from continuing operations
(25.0
)
 
6.4

Income from discontinued operations, net of income taxes
8.1

 
11.8

Net (loss) income
(16.9
)
 
18.2

Less: Net income attributable to noncontrolling interests

 
(0.4
)
Net (loss) income attributable to GCP shareholders
$
(16.9
)
 
$
17.8

Amounts Attributable to GCP Shareholders:
 
 
 
(Loss) income from continuing operations attributable to GCP shareholders
(25.0
)
 
6.0

Income from discontinued operations, net of income taxes
8.1

 
11.8

Net (loss) income attributable to GCP shareholders
$
(16.9
)
 
$
17.8

Earnings Per Share Attributable to GCP Shareholders
 
 
 
Basic earnings per share:
 
 
 
(Loss) income from continuing operations attributable to GCP shareholders
$
(0.35
)
 
$
0.08

Income from discontinued operations, net of income taxes
$
0.11

 
$
0.17

Net (loss) income attributable to GCP shareholders
$
(0.24
)
 
$
0.25

Weighted average number of basic shares
71.2


70.6

Diluted earnings per share:
 
 
 
(Loss) income from continuing operations attributable to GCP shareholders
$
(0.35
)
 
$
0.08

Income from discontinued operations, net of income taxes
$
0.11

 
$
0.17

Net (loss) income attributable to GCP shareholders
$
(0.24
)
 
$
0.25

Weighted average number of diluted shares
71.2

 
70.9


The Notes to Consolidated Financial Statements are an integral part of these statements.
4


Table of Contents

GCP Applied Technologies Inc.
Consolidated Balance Sheets (unaudited)
(In millions, except par value and shares)
March 31,
2017
 
December 31,
2016
ASSETS
 
 
 
Current Assets
 
 
 
Cash and cash equivalents
$
109.5

 
$
146.1

Trade accounts receivable, less allowance of $4.6 (2016—$4.5)
169.4

 
166.6

Inventories
101.3

 
89.3

Other current assets
53.1


42.9

Current assets held for sale
120.3

 
108.9

Total Current Assets
553.6

 
553.8

Properties and equipment, net
191.5

 
192.2

Goodwill
115.1

 
114.9

Technology and other intangible assets, net
51.0

 
52.6

Deferred income taxes
59.0

 
76.9

Overfunded defined benefit pension plans
22.0

 
21.2

Other assets
23.7


22.4

Noncurrent assets held for sale
61.8

 
55.8

Total Assets
$
1,077.7

 
$
1,089.8

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
 
 
 
Current Liabilities
 
 
 
Debt payable within one year
$
37.9

 
$
47.9

Accounts payable
104.7

 
95.4

Other current liabilities
96.9

 
119.5

Current liabilities held for sale
54.8

 
48.7

Total Current Liabilities
294.3

 
311.5

Debt payable after one year
782.7

 
783.0

Deferred income taxes
5.9

 
6.6

Unrecognized tax benefits
10.9

 
9.7

Underfunded and unfunded defined benefit pension plans
86.2

 
83.2

Other liabilities
13.8

 
13.9

Noncurrent liabilities held for sale
21.6

 
20.9

Total Liabilities
1,215.4

 
1,228.8

Commitments and Contingencies - Note 7

 

Stockholders' (Deficit) Equity
 
 
 
Common stock issued, par value $0.01; 300,000,000 shares authorized; outstanding: 71,450,751
0.7

 
0.7

Paid-in capital
17.2

 
11.0

Accumulated deficit
(21.6
)
 
(4.7
)
Accumulated other comprehensive loss
(135.0
)
 
(147.6
)
Treasury stock
(3.0
)
 
(2.1
)
Total GCP's Shareholders' (Deficit) Equity
(141.7
)
 
(142.7
)
Noncontrolling interests
4.0

 
3.7

Total Stockholders' (Deficit) Equity
(137.7
)
 
(139.0
)
Total Liabilities and Stockholders' (Deficit) Equity
$
1,077.7

 
$
1,089.8


The Notes to Consolidated Financial Statements are an integral part of these statements.
5


Table of Contents

GCP Applied Technologies Inc.
Consolidated Statements of Comprehensive Income (Loss) (unaudited)
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Net (loss) income
$
(16.9
)
 
$
18.2

Other comprehensive income (loss):
 
 
 
Currency translation adjustments
12.6

 
3.9

Loss from hedging activities, net of income taxes

 
(0.2
)
Total other comprehensive income attributable to noncontrolling interests

 
0.2

Total other comprehensive income
12.6

 
3.9

Comprehensive (loss) income
(4.3
)
 
22.1

Less: Comprehensive income attributable to noncontrolling interests

 
(0.6
)
Comprehensive (loss) income attributable to GCP shareholders
$
(4.3
)
 
$
21.5



The Notes to Consolidated Financial Statements are an integral part of these statements.
6


Table of Contents

GCP Applied Technologies Inc.
Consolidated Statements of Stockholders' Equity (Deficit) (unaudited)
 
Common Stock
 
Treasury Stock
 
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Number of Shares
 
Par Value
 
Number of Shares
 
Cost
 
Additional Paid-in Capital
 
Accumulated Deficit
 
Net Parent Investment
 
Accumulated Other Comprehensive Loss
 
Noncontrolling Interests
 
Total Stockholders' Equity (Deficit)
Balance, December 31, 2015

 
$

 

 
$

 
$

 
$

 
$
598.3

 
$
(127.7
)
 
$
3.5

 
$
474.1

Net income

 

 

 

 

 
10.6

 
7.2

 

 
0.4

 
18.2

Net transfer to parent

 

 

 

 

 

 
(677.9
)
 

 

 
(677.9
)
Issuance of common stock and reclassification of net parent investment in connection with Separation
70.5

 
0.7

 

 

 

 
(73.1
)
 
72.4

 

 

 

Issuance of common stock in connection with stock plans
0.1

 

 

 

 

 

 

 

 

 

Share-based compensation

 

 

 

 
0.7

 

 

 

 

 
0.7

Exercise of stock options
0.2

 

 

 

 
0.6

 

 

 

 

 
0.6

Treasury stock purchased under GCP 2016 Stock Incentive Plan

 

 
0.1

 
(1.7
)
 

 

 

 

 

 
(1.7
)
Other comprehensive income

 

 

 

 

 

 

 
3.7

 
0.2

 
3.9

Balance, March 31, 2016
70.8

 
$
0.7

 
0.1

 
$
(1.7
)
 
$
1.3

 
$
(62.5
)
 
$

 
$
(124.0
)
 
$
4.1

 
$
(182.1
)
Balance, December 31, 2016
71.2

 
$
0.7

 
0.1

 
$
(2.1
)
 
$
11.0

 
$
(4.7
)
 
$

 
$
(147.6
)
 
$
3.7

 
$
(139.0
)
Net loss

 

 

 

 

 
(16.9
)
 

 

 

 
(16.9
)
Issuance of common stock in connection with stock plans
0.1

 

 

 

 

 

 

 

 

 

Share-based compensation

 

 

 

 
2.1

 

 

 

 

 
2.1

Exercise of stock options
0.3

 

 

 

 
4.1

 

 

 

 

 
4.1

Treasury stock purchased under GCP 2016 Stock Incentive Plan

 

 

 
(0.9
)
 

 

 

 

 

 
(0.9
)
Other comprehensive income

 

 

 

 

 

 

 
12.6

 

 
12.6

Dividends and other changes in noncontrolling interest

 

 

 

 

 

 

 

 
0.3

 
0.3

Balance, March 31, 2017
71.6

 
$
0.7

 
0.1

 
$
(3.0
)
 
$
17.2

 
$
(21.6
)
 
$

 
$
(135.0
)
 
$
4.0

 
$
(137.7
)

The Notes to Consolidated Financial Statements are an integral part of these statements.
7


Table of Contents

GCP Applied Technologies Inc.
Consolidated Statements of Cash Flows (unaudited)
 
Three Months Ended March 31,
(In millions)
2017
 
2016
OPERATING ACTIVITIES
 
 
 
Net (loss) income
$
(16.9
)
 
$
18.2

Less: Income from discontinued operations
8.1

 
11.8

(Loss) income from continuing operations
(25.0
)
 
6.4

Reconciliation to net cash (used in) provided by operating activities:
 
 
 
Depreciation and amortization
8.4

 
7.4

Amortization of debt discount and financing costs
0.8

 
0.5

Stock-based compensation expense
2.1

 
1.1

Currency and other losses in Venezuela
0.1

 
0.1

Deferred income taxes
8.5

 
(7.4
)
(Gain) loss on disposal of property and equipment
(0.8
)
 
0.7

Changes in assets and liabilities, excluding effect of currency translation:
 
 
 
Trade accounts receivable
(0.4
)
 
(5.5
)
Inventories
(12.7
)
 
(1.0
)
Accounts payable
16.7

 
7.3

Pension assets and liabilities, net
1.9

 
1.1

Other assets and liabilities, net
(27.6
)
 
(2.5
)
Net cash (used in) provided by operating activities from continuing operations
(28.0
)
 
8.2

Net cash provided by operating activities from discontinued operations
14.3

 
16.3

Net cash (used in) provided by operating activities
(13.7
)
 
24.5

INVESTING ACTIVITIES
 
 
 
Capital expenditures
(12.7
)
 
(12.7
)
Other investing activities
2.9

 
0.1

Net cash used in investing activities from continuing operations
(9.8
)
 
(12.6
)
Net cash used in investing activities from discontinued operations
(2.4
)
 
(1.0
)
Net cash used in investing activities
(12.2
)
 
(13.6
)
FINANCING ACTIVITIES
 
 
 
Borrowings under credit arrangements
1.6

 
283.1

Repayments under credit arrangements
(13.0
)
 
(9.1
)
Proceeds from issuance of notes

 
525.0

Cash paid for debt financing costs

 
(18.2
)
Share repurchase under GCP 2016 Stock Incentive Plan
(0.9
)
 
(1.7
)
Proceeds from exercise of stock options
3.5

 
0.2

Transfers to parent, net

 
(758.7
)
Net cash (used in) provided by financing activities from continuing operations
(8.8
)
 
20.6

Net cash provided by (used in) financing activities from discontinued operations
0.4

 
(5.8
)
Net cash (used in) provided by financing activities
(8.4
)
 
14.8

Effect of currency exchange rate changes on cash and cash equivalents
2.8

 
2.4

(Decrease) increase in cash and cash equivalents
(31.5
)
 
28.1

Cash and cash equivalents, beginning of period
163.3

 
98.6

Cash and cash equivalents, end of period
131.8

 
126.7

Less: Cash and cash equivalents of discontinued operations
22.3

 
15.9

Cash and cash equivalents of continuing operations, end of period
$
109.5

 
$
110.8


The Notes to Consolidated Financial Statements are an integral part of these statements.
8


Table of Contents

Notes to Consolidated Financial Statements

1. Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies
On January 27, 2016, GCP entered into a separation and distribution agreement pursuant to which W.R. Grace & Co. ("Grace") agreed to transfer its Grace Construction Products operating segment and the packaging technologies business, operated under the “Darex” name, of its Grace Materials Technologies operating segment to GCP (the "Separation"). The Separation occurred on February 3, 2016, by means of a pro rata distribution to Grace stockholders of all of the then-outstanding shares of Company common stock, at which time GCP became an independent public company and its common stock listed and began trading under the symbol "GCP" on the New York Stock Exchange.
GCP is engaged in the production and sale of specialty construction chemicals and specialty building materials through two operating segments. Specialty Construction Chemicals ("SCC") manufactures and markets concrete admixtures and cement additives. Specialty Building Materials ("SBM") manufactures and markets sheet and liquid membrane systems that protect structures from water, air and vapor penetration, fireproofing and other products designed to protect the building envelope.
On March 2, 2017, GCP announced the sale of its Darex Packaging Technologies ("Darex") business to Henkel AG & Co. KgaA (“Henkel”). As discussed further below under "Discontinued Operations," the results of operations for Darex have been excluded from continuing operations and segment results for all periods presented.
Basis of Presentation
The accompanying Consolidated Financial Statements are presented on a consolidated basis and include all of the accounts and operations of GCP and its majority-owned subsidiaries. The financial statements reflect the financial position, results of operations and cash flows of GCP in accordance with generally accepted accounting principles in the United States of America ("GAAP") and with the instructions to Form 10-Q and Article 10 of SEC Regulation S-X for interim financial information.
The interim financial statements presented herein are unaudited and should be read in conjunction with the Consolidated Financial Statements presented in the Company's 2016 Annual Report on Form 10-K. Such financial statements reflect all adjustments that, in the opinion of management, are necessary for a fair statement of the results of the interim periods presented; all such adjustments are of a normal recurring nature except for the impacts of adopting new accounting standards as discussed below. All significant intercompany accounts and transactions have been eliminated. The results of operations for the three-month period ended March 31, 2017 are not necessarily indicative of the results of operations for the year ending December 31, 2017 .
Discontinued Operations     As noted above, on March 2, 2017, the Company entered into a final, binding and irrevocable offer letter (the "Offer Letter") with Henkel, pursuant to which Henkel made a binding offer to acquire Darex for approximately  $1.05 billion (the "Acquisition"). Pursuant to the terms of the Offer Letter, following the conclusion of statutory employee consultation processes in connection with the Acquisition by the relevant works councils in France, the Company accepted Henkel’s offer and countersigned the Stock and Asset Purchase Agreement (the “Purchase Agreement”) with respect to the Acquisition on April 28, 2017. The Purchase Agreement was previously executed by Henkel. Completion of the Acquisition remains subject to the satisfaction or waiver of customary closing conditions, including regulatory approvals.
In conjunction with this transaction and applicable GAAP, the assets and liabilities related to Darex have been reclassified and reflected as "held for sale" on the Consolidated Balance Sheets for all periods presented. Additionally, Darex has been reclassified and reflected as "discontinued operations" on the Consolidated Statements of Operations and Consolidated Statements of Cash Flows for all periods presented. Unless otherwise noted, the information throughout the Notes to the Consolidated Financial Statements pertains only to the continuing operations of GCP. Refer to Note 14 for further discussion of the Acquisition.

9


Notes to Consolidated Financial Statements (Continued)

Use of Estimates     The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements, and the reported amounts of revenues and expenses for the periods presented. Actual amounts could differ from those estimates, and the differences could be material. Changes in estimates are recorded in the period identified. GCP's accounting measurements that are most affected by management's estimates of future events are:
Contingent liabilities, which depend on an assessment of the probability of loss and an estimate of ultimate resolution cost, that may arise from circumstances such as legal disputes, environmental remediation, product liability claims, material commitments (refer to Note 7 to the Consolidated Financial Statements) and income taxes (refer to Note 4 to the Consolidated Financial Statements);
Pension and postretirement liabilities that depend on assumptions regarding participant life spans, future inflation, discount rates and total returns on invested funds (refer to Note 5 to the Consolidated Financial Statements); and
Realization values of net deferred tax assets, which depend on projections of future taxable income (refer to Note 4 to the Consolidated Financial Statements).
Reclassifications     Certain amounts in prior period financial statements have been reclassified to conform to the current period presentation. Such reclassifications have not materially affected previously reported amounts.
Income Tax     As a global enterprise, GCP is subject to a complex array of tax regulations and must make assessments of applicable tax law and judgments in estimating its ultimate income tax liability. Refer to Note 4 for details regarding estimates used in accounting for income tax matters including unrecognized tax benefits.
Stock-Based Compensation Expense     Prior to the Separation, GCP was allocated stock-based compensation expense from Grace related to GCP employees receiving awards denominated in Grace equity instruments. In accordance with an employee matters agreement entered into between Grace and GCP on January 27, 2016 in connection with the Separation (the "Employee Matters Agreement"), previously outstanding stock-based compensation awards granted under Grace's equity compensation programs prior to the Separation and held by certain executives and employees of GCP and Grace were adjusted to reflect the impact of the Separation on these awards. To preserve the aggregate intrinsic value of these stock-based compensation awards, as measured immediately before and immediately after the Separation, each holder of Grace stock-based compensation awards generally received an adjusted award consisting of either (i) both a stock-based compensation award denominated in Grace equity as it existed subsequent to the Separation and a stock-based compensation award denominated in GCP equity or (ii) solely a stock-based compensation award denominated in the equity of the company at which the person was employed following the Separation. In the Separation, the determination as to which type of adjustment applied to a holder’s previously outstanding Grace award was based upon the type of stock-based compensation award that was to be adjusted and the date on which the award was originally granted under the Grace equity compensation programs prior to the Separation. Under the Employee Matters Agreement, GCP retains certain obligations related to all stock- and cash-settled stock-based compensation awards denominated in GCP equity, regardless of whether the holder is a GCP or Grace employee. Following the Separation, the Company records stock-based compensation expense for equity awards in accordance with authoritative accounting guidance.
Currency Translation     Assets and liabilities of foreign subsidiaries (other than those located in countries with highly inflationary economies) are translated into U.S. dollars at current exchange rates, while revenues, costs and expenses are translated at average exchange rates during each reporting period. The resulting currency translation adjustments are included in accumulated other comprehensive loss in the Consolidated Balance Sheets. The financial statements of any subsidiaries located in countries with highly inflationary economies are remeasured as if the functional currency were the U.S. dollar; the remeasurement creates translation adjustments that are reflected in net income in the Consolidated Statements of Operations.

10


Notes to Consolidated Financial Statements (Continued)

Effective January 1, 2010, GCP began to treat Venezuela as a highly inflationary economy. As a result, the functional currency of its Venezuelan subsidiary became the U.S. dollar; therefore, all translation adjustments are reflected in net income in the accompanying Consolidated Statements of Operations. Effective September 30, 2015, the Company began accounting for its results in Venezuela at the SIMADI rate. In mid-February 2016, changes to the currency exchange systems were announced that eliminated the SICAD exchange rate and replaced the name SIMADI rate with DICOM. The DICOM rate was 708 bolivars to one U.S. dollar at March 31, 2017, an increase of approximately 4.9% from the rate at December 31, 2016, resulting in an immaterial impact on income from continuing operations.

In March 2017, the Venezuelan government announced that a new exchange rate would be introduced to replace the DICOM rate, although further details have not been publicly announced. Management believes the new exchange rate would result in a further devaluation of the local currency and additional currency remeasurement losses in net income. At March 31, 2017, monetary net assets denominated in local currency within the Company's Venezuela subsidiary were $8.7 million , of which $5.0 million has been reflected as "held for sale" on the Consolidated Balance Sheet .
During the quarter ended March 31, 2017, except as discussed above, there were no material changes to the Company's significant accounting and financial reporting policies from those reflected in the Annual Report on Form 10-K for the year ended December 31, 2016.
Recently Issued Accounting Standards
Business Combinations
In January 2017, the FASB issued Accounting Standards Update ("ASU") 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business , which clarifies the definition of a business when evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The update provides that when substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the transaction does not involve a business. The standard is effective for the Company on January 1, 2018, with early application permitted for certain transactions. GCP will consider the provisions of this update in conjunction with qualifying transactions in periods subsequent to March 31, 2017, as applicable.
Goodwill
In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350) . This ASU modifies the concept of impairment from the condition that exists when the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting unit exceeds its fair value, which eliminates Step 2 from the goodwill impairment test. The standard is effective for the Company for annual or any interim goodwill impairment tests beginning on or after January 1, 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017.
Revenue from Contracts with Customers
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) . This update is intended to remove inconsistencies and weaknesses in revenue requirements; provide a more robust framework for addressing revenue issues; improve comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; provide more useful information to users of financial statements through improved disclosure requirements; and simplify the preparation of financial statements by reducing the number of requirements to which an entity must refer. The new requirements were to be effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years, with early adoption not permitted. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers-Deferral of the Effective Date , deferring the effective date by one year but permitting adoption as of the original effective date. The revised standard allows for two methods of adoption: (a) full retrospective adoption, meaning the standard is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying the new standard is recognized as an adjustment to the opening retained earnings balance. The standard will be effective for the Company on January 1, 2018.

11


Notes to Consolidated Financial Statements (Continued)

In addition to the expanded disclosures regarding revenue, this guidance may impact timing of revenue recognition in some arrangements with variable consideration or contracts for the sale of goods and services. GCP is currently evaluating the available transition methods and the potential impact of the standard on its Consolidated Financial Statements and related disclosures. Specifically, management has established a mutli-disciplinary project team to evaluate and implement Topic 606, and the project team is currently collecting information from key organizational stakeholders to identify revenue streams for focused individual contract analysis.
Leases
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) , which is intended to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term, including optional payments where they are reasonably certain to occur. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. GCP is currently evaluating the potential impact on its Consolidated Financial Statements and related disclosures.

Other new pronouncements issued but not effective until after March 31, 2017 are not expected to have a material impact on the Company's financial position, results of operations or liquidity.
Recently Adopted Accounting Standards
Pension and Other Postretirement Benefit Costs
In March 2017, the FASB issued ASU 2017-07, Compensation—Retirement Benefits (Topic 715) : Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which changes certain presentation and disclosure requirements for employers that sponsor defined benefit pension and other postretirement benefit plans. The amendments in this ASU require entities to (1) report the service cost component of net periodic pension/postretirement benefit cost in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period; (2) capitalize only the service cost component of net periodic pension/postretirement benefit cost (when applicable); and (3) present other components of net periodic pension/postretirement benefit cost separately from the service cost component and outside a subtotal of income from operations (if applicable). The standard is effective for the Company on January 1, 2018, with early adoption permitted as of January 1, 2017.
GCP elected to early adopt this standard in the first quarter of 2017 and has reflected only the service cost component of net periodic pension/postretirement benefit cost in "Cost of goods sold" and presented the other components of net periodic pension/postretirement benefit cost in "Other (income) expense, net," within the Consolidated Statements of Operations. In accordance with the standard, GCP utilized prior period footnote disclosures as a practical expedient to apply these retrospective presentation requirements and will prospectively apply the capitalization requirements. GCP's adoption of this standard did not have a material effect on the accompanying Consolidated Financial Statements.
Inventory
In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . The update requires that inventory be measured at the lower of cost or net realizable value for entities using first-in, first-out ("FIFO") or average cost methods. The new requirements are effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years, with early adoption permitted. GCP adopted this standard for the 2017 first quarter and there were no material effects on the accompanying Consolidated Financial Statements.

12


Notes to Consolidated Financial Statements (Continued)

2. Inventories
Inventories are stated at the lower of cost or net realizable value. GCP determines cost using the FIFO methodology. Inventories presented on GCP's Consolidated Balance Sheets consisted of the following:
(In millions)
March 31,
2017
 
December 31,
2016
Raw materials
$
35.9

 
$
35.7

In process
3.4

 
3.6

Finished products and other
62.0

 
50.0

Total inventories
$
101.3

 
$
89.3

Included above as "other" within "Finished products and other" are finished products purchased rather than produced by GCP of $12.7 million and $10.9 million as of March 31, 2017 and December 31, 2016 , respectively.
3. Debt and Other Financial Instruments
Components of Debt
(In millions)
March 31,
2017
 
December 31,
2016
9.5% Senior Notes due 2023, net of unamortized debt issuance costs of $7.1  at March 31, 2017 (2016 $7.3)
$
517.9

 
$
517.7

Term Loan due 2022, net of unamortized discount of $2.3  and unamortized debt issuance costs of $4.1  at March 31, 2017 (1) (2016 $2.4, $4.3)
265.9

 
266.2

Revolving credit facility due 2021 (2)
15.0

 
25.0

Other borrowings (3)
21.8

 
22.0

Total debt
820.6

 
830.9

Less debt payable within one year
37.9

 
47.9

Debt payable after one year
$
782.7

 
$
783.0

Weighted average interest rates on total debt
7.7
%
 
7.5
%
__________________________
(1)  
Interest at LIBOR + 325 bps with a 75 bps LIBOR floor at March 31, 2017 .
(2)  
Interest at LIBOR +200 bps at March 31, 2017 .
(3)  
Represents borrowings under various lines of credit and other borrowings, primarily by non-U.S. subsidiaries.
The principal maturities of debt outstanding (net of unamortized discounts and debt issuance costs) at March 31, 2017 , were as follows:
 
(In millions)
2017
$
37.1

2018
3.4

2019
3.4

2020
3.4

2021
2.8

Thereafter
770.5

Total debt
$
820.6


13


Notes to Consolidated Financial Statements (Continued)

Credit Agreement
On February 3, 2016, GCP entered into a credit agreement (the “Credit Agreement”) that provides for senior secured credit facilities (the “Credit Facilities”) in an aggregate principal amount of $525.0 million , consisting of:
(a)
term loan (the “Term Loan”) in an aggregate principal amount of $275.0 million maturing in 2022; and
(b)
$250.0 million revolving credit facility (the "Revolving Loan") due in 2021.
The Term Loan principal balance is scheduled to be repaid in equal quarterly installments in aggregate annual amounts equal to 1.0% of the original principal amount, with the balance due upon the maturity date.
The Credit Agreement contains customary affirmative covenants, including, but not limited to (i) maintenance of legal existence and compliance with laws and regulations; (ii) delivery of consolidated financial statements and other information; (iii) payment of taxes; (iv) delivery of notices of defaults and certain other material events; and (v) maintenance of adequate insurance. The Credit Agreement also contains customary negative covenants, including but not limited to restrictions on (i) dividends on, and redemptions of, equity interests and other restricted payments; (ii) liens; (iii) loans and investments; (iv) the sale, transfer or disposition of assets and businesses; (vi) transactions with affiliates; and (vii) a maximum total leverage ratio. Certain debt covenants may restrict the entity's ability as it relates to dividends, acquisitions and other borrowings. The Credit Agreement contains conditions that would require mandatory principal payments in advance of the maturity date of the Term Loan and Revolving Credit Facility; the Company was in compliance with all terms as of March 31, 2017 .
Events of default under the Credit Agreement include, but are not limited to: (i) failure to pay principal, interest, fees or other amounts under the Credit Agreement when due, taking into account any applicable grace period; (ii) any representation or warranty proving to have been incorrect in any material respect when made; (iii) failure to perform or observe covenants or other terms of the Credit Agreement subject to certain grace periods; (iv) a cross-default and cross-acceleration with certain other material debt; (v) bankruptcy events; (vi) certain defaults under ERISA; and (vii) the invalidity or impairment of security interests. There are no events of default as of March 31, 2017 .
The Credit Facilities are secured on a first priority basis by a perfected security interest in, and mortgages on, substantially all tangible and intangible personal property and material fee-owned real property (specifically properties in Chicago, Illinois and Mount Pleasant, Tennessee) of the Company, a pledge of 100% of the equity of each material U.S. subsidiary of the Company and 65% of the equity of the United Kingdom holding company.
During 2016, GCP refinanced the existing Credit Agreement with a syndicate of banks (the “Amended Credit Agreement”). The Amended Credit Agreement reduced the interest rate margins applicable to the Term Loan from base rate plus a margin of 3.5% or LIBOR plus a margin of 4.5% to a base rate plus a margin of 2.25% or LIBOR plus a margin of 3.25% at GCP’s option. The outstanding principal balance was replaced by a like aggregate principal balance with substantially similar terms to the Credit Agreement.
The interest rate per annum applicable to the Revolving Loan is equal to, at GCP’s option, either a base rate plus a margin ranging from 0.5% to 1.0% or LIBOR plus a margin ranging from 1.5% to 2.0% , in either case based upon the total leverage ratio of GCP and its restricted subsidiaries. During 2016, GCP borrowed $25.0 million on its Revolving Loan and used the funds, together with cash on hand, to acquire Halex Corporation. Of the $25.0 million draw, $15.0 million was outstanding as of March 31, 2017 alongside approximately $9 million in outstanding letters of credit, which reduced available credit under that facility to  $226.0 million .
The summary above of the Credit Agreement and Amended Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreements, copies of which have been filed with the SEC.
Senior Notes
On January 27, 2016, GCP issued $525.0 million aggregate principal amount of 9.5% Senior Notes due 2023 (the “Notes”). Interest is payable semi-annually in arrears on February 1 and August 1 of each year.

14


Notes to Consolidated Financial Statements (Continued)

The Notes were issued subject to covenants that limit the Company's and certain of its subsidiaries’ ability, subject to certain exceptions and qualifications, to (i) create or incur liens on assets, (ii) incur additional debt (iii) sell certain assets (iv) make certain investments and acquisitions, merge or sell or otherwise dispose of all or substantially all assets.
Divestiture of Darex
As discussed in Note 1, on March 2, 2017, the Company entered into the Offer Letter with Henkel, pursuant to which Henkel made a binding offer to acquire Darex for approximately  $1.05 billion , subject to working capital and certain other adjustments. The proposed sale of Darex is a permitted transaction under the Company's Credit Agreement and the Indenture governing the Notes. Under the Credit Agreement and Indenture, the Company would be required to use any net cash proceeds from the proposed sale of Darex to prepay debt or make investments in its business over a period of approximately 18 months . Refer to Note 14 for further discussion of the proposed sale of Darex.
During 2016, GCP incurred debt issuance costs relating to issuance of the Notes, Term Loan, and Revolving Loan of $8.0 million , $5.0 million and $5.2 million , respectively. GCP deducted the debt issuance costs relating to the Notes and the Term Loan from the carrying amounts presented on its Consolidated Balance Sheet and is amortizing those costs over the terms of the underlying obligations.
GCP classified debt issuance costs relating to the Revolving Loan in "Other assets" on its Consolidated Balance Sheet and is amortizing those costs over the term of the Revolving Loan. The unamortized portion of these costs was $4.0 million as of March 31, 2017 and $4.2 million as of December 31, 2016 .
During the first quarter of 2016, GCP used certain proceeds from the Notes and Credit Facilities to fund a distribution to Grace in an amount of $750.0 million related to the Separation. Approximately $50 million was retained to meet operating requirements and to pay fees associated with the debt financing and other costs of the Separation that may be incurred subsequent to the Separation. Related party debt of approximately $42 million and related interest was transferred from Grace to GCP in connection with the Separation.
Debt Fair Value
At March 31, 2017 , the carrying amounts and fair values of GCP's debt were as follows:
 
March 31, 2017
 
December 31, 2016
(In millions)
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
9.5% Senior Notes due 2023
$
517.9

 
$
595.7

 
$
517.7

 
$
603.1

Term Loan due 2022
265.9

 
268.9

 
266.2

 
274.6

Revolving credit facility due 2021
15.0

 
15.0

 
25.0

 
25.0

Other borrowings
21.8

 
21.8

 
22.0

 
22.0

Total debt
$
820.6

 
$
901.4

 
$
830.9

 
$
924.7

Fair value is determined based on Level 2 inputs, including expected future cash flows (discounted at market interest rates), estimated current market prices and quotes from financial institutions. The decrease in fair value as of March 31, 2017 was due primarily to the Federal Reserve raising the federal funds target rate during the first quarter of 2017.

15


Notes to Consolidated Financial Statements (Continued)

4. Income Taxes
The income tax provision on continuing operations for the three months ended March 31, 2017 and 2016 was $11.6 million and $1.7 million , respectively, representing effective tax rates of ( 86.6% ) and 21.0% , respectively. The increase in the effective tax rate for the three month period of 107.6 percentage points compared to the same period in 2016 was primarily due to the recording of valuation allowances against certain U.S., Brazil, and Turkey deferred tax assets and a change in the Company’s assertion that it is indefinitely reinvested in Mexico, as further discussed below. The difference between the provision for income taxes at the U.S. federal income tax rate of 35% and GCP’s overall income tax rate is summarized below.
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Tax provision at U.S. federal income tax rate
$
(4.7
)
 
$
2.8

Change in provision resulting from:
 
 
 
Valuation allowance
13.8

 

Tax on undistributed foreign earnings
1.9

 

Effect of tax rates in foreign jurisdictions
0.7

 
(0.6
)
Permanent items and other
(0.1
)
 
(0.5
)
Provision for income taxes
$
11.6

 
$
1.7

For the three months ended March 31, 2017 and 2016, GCP recorded income tax expense on discontinued operations of $1.8 million and $5.9 million , respectively. Refer to Note 14 for further details.

As of December 31, 2016, GCP had the intent and ability to indefinitely reinvest undistributed earnings of its foreign subsidiaries outside the United States. During the first quarter of 2017, GCP determined it could no longer assert it is indefinitely reinvested in Mexico because that entity is anticipated to be sold as part of the Darex transaction. The tax associated with its outside book and tax basis difference in Mexico was recorded during the quarter as a discrete item resulting in a tax expense of $1.9 million . GCP believes that the anticipated sale of Darex is a one-time, non-recurring event and that recognition of deferred taxes of undistributed earnings during 2017 would not have occurred if not for the anticipated sale. As of March 31, 2017, GCP has the intent and ability to indefinitely reinvest undistributed earnings of all its other foreign subsidiaries outside the United States. Subsequent to the anticipated sale of Darex, GCP expects undistributed prior-year earnings of its foreign subsidiaries to remain indefinitely reinvested except in certain instances where repatriation of such earnings would result in minimal or no tax. GCP bases this assertion on:

(1)
the expectation that it will satisfy its U.S. cash obligations in the foreseeable future without requiring the repatriation of prior-year foreign earnings;
(2)
plans for significant and continued reinvestment of foreign earnings in organic and inorganic growth initiatives outside the U.S.; and
(3)
remittance restrictions imposed by local governments.

GCP will continually analyze and evaluate its cash needs to determine the appropriateness of its indefinite reinvestment assertion.


16


Notes to Consolidated Financial Statements (Continued)

In evaluating GCP's ability to realize its deferred tax assets, GCP considers all reasonably available positive and negative evidence, including recent earnings experience, expectations of future taxable income and the tax character of that income, the period of time over which the temporary differences become deductible and the carryforward and/or carryback periods available to GCP for tax reporting purposes in the related jurisdiction. In estimating future taxable income, GCP relies upon assumptions and estimates about future activities, including the amount of future federal, state and foreign pretax operating income that GCP will generate; the reversal of temporary differences; and the implementation of feasible and prudent tax planning strategies. GCP records a valuation allowance to reduce deferred tax assets to the amount that it believes is more likely than not to be realized. During the first quarter of 2017, GCP determined it is more likely than not a portion of its deferred tax assets will not be realized. As a result, GCP recorded valuation allowances on those deferred tax assets during the quarter as discrete items, as they are significant, unusual and infrequent in nature. The allowances recorded relate to $4.3 million of U.S. foreign tax credit carryovers and $9.1 million and $0.4 million of Brazil and Turkey deferred tax assets, respectively, relating primarily to net operating loss carryovers. The determination to record the valuation allowances in the first quarter was made predominantly due to the anticipated sale of Darex and its impact on future taxable income and the ability to utilize those tax assets.
As also discussed in Note 1, on February 3, 2016 the Separation of Grace and GCP was completed. In conjunction with the Separation, GCP increased its deferred tax assets and prepaid taxes in the U.S. by approximately $74 million , which primarily relates to the step up in tax basis and transfer of a net pension liability.
In connection with the Separation, GCP and Grace entered into various agreements that govern the relationship between the parties going forward, including a tax matters agreement (the "Tax Sharing Agreement"). Under the Tax Sharing Agreement, which was entered into on the distribution date, GCP and Grace will indemnify and hold each other harmless in accordance with the principles outlined therein.

During the first quarter of 2017, GCP reached a proposed favorable settlement with the Canada Revenue Agency for tax years 2007-2015. As a result of the proposed settlement, a tax benefit of $1.5 million , primarily for an anticipated refund of previously paid tax, was recorded during the quarter. GCP is required to pay Grace for the amount of the expected tax refund pursuant to the Tax Sharing Agreement in effect. GCP also recorded a charge to its U.S. deferred tax assets of $1.6 million related to the settlement due to the reduction of its step-up in tax basis. Both adjustments were recorded as discrete tax items.

5. Pension Plans and Other Postretirement Benefit Plans
Postretirement Benefits Other Than Pensions     Prior to the Separation, Grace provided postretirement life insurance benefits for retired employees of certain U.S. business units and certain divested business units. GCP’s allocated income for these postretirement life insurance benefits plan was $1.2 million for the three months ended March 31, 2016 . The postretirement life insurance benefits plan liability related to GCP employees who were participants in this plan at the time of Separation was legally transferred to GCP.
During the second half of 2016, GCP eliminated retiree life insurance benefits at the remaining bargaining locations and, as a result, did not recognize any related amounts in its Consolidated Statement of Operations for the three months ended March 31, 2017.
Pension Plans     GCP sponsors certain defined benefit pension plans, primarily in the U.S. and the U. K. in which GCP employees participate. GCP records an asset or liability to recognize the funded status of these pension plans in its Consolidated Balance Sheets.

17


Notes to Consolidated Financial Statements (Continued)

The following table presents the funded status of GCP's overfunded, underfunded and unfunded defined pension plans from continuing operations:
(In millions)
March 31,
2017
 
December 31,
2016
Overfunded defined benefit pension plans
$
22.0

 
$
21.2

Underfunded defined benefit pension plans
(57.7
)
 
(55.6
)
Unfunded defined benefit pension plans
(28.5
)
 
(27.6
)
Total underfunded and unfunded defined benefit pension plans
(86.2
)
 
(83.2
)
Pension liabilities included in other current liabilities
(0.5
)
 
(0.4
)
Net funded status
$
(64.7
)
 
$
(62.4
)
Overfunded plans include several advance-funded plans for which the fair value of the plan assets exceeds the projected benefit obligation ("PBO"). This group of plans was overfunded by $22.0 million as of March 31, 2017 , and the overfunded status is reflected as assets in "Overfunded defined benefit pension plans" in the Consolidated Balance Sheets. Underfunded plans include a group of advance-funded plans that are underfunded on a PBO basis. Unfunded plans include several plans that are funded on a pay-as-you-go basis, and therefore, the entire PBO is unfunded. As of March 31, 2017 , the combined balance of $86.7 million for the underfunded and unfunded plans included as liabilities in the Consolidated Balance Sheets is comprised of current and non-current components of $0.5 million in "Other current liabilities" and $86.2 million in "Underfunded and unfunded defined benefit pension plans," respectively.
Components of Net Periodic Benefit Cost (Income)
 
Three Months Ended March 31,
 
2017
 
2016
 
Pension
 
Other Post
Retirement
 
Pension
 
Other Post
Retirement
(In millions)
U.S.
 
Non-U.S.
 
 
U.S.
 
Non-U.S.
 
Service cost
$
1.9

 
$
1.0

 
$

 
$
1.5

 
$
0.9

 
$

Interest cost
1.5

 
1.5

 

 
1.2

 
2.1

 

Expected return on plan assets
(1.4
)
 
(1.7
)
 

 
(1.2
)
 
(2.3
)
 

Amortization of prior service credit

 

 

 

 

 
(0.1
)
Net periodic benefit cost (income) (1)
$
2.0

 
$
0.8

 
$

 
$
1.5

 
$
0.7

 
$
(0.1
)
Less: Discontinued operations

 
0.2

 

 

 
0.3

 

Net periodic benefit cost (income) from continuing operations
$
2.0

 
$
0.6

 
$

 
$
1.5

 
$
0.4

 
$
(0.1
)
_______________________________
(1)  
Includes expense that was allocated to Grace of $0.1 million  for the three months ended March 31, 2016 .
Plan Contributions and Funding     GCP intends to satisfy its funding obligations under the U.S. qualified pension plans and to comply with all of the requirements of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"). For ERISA purposes, funded status is calculated on a different basis than under GAAP.
GCP intends to fund non-U.S. pension plans based on applicable legal requirements as well as actuarial and trustee recommendations.
Defined Contribution Retirement Plan     As part of the Separation, GCP established a defined contribution retirement plan for its employees in the U.S. This plan is qualified under section 401(k) of the U.S. tax code. Currently, GCP contributes an amount equal to 100% of employee contributions, up to 6% of an individual employee's salary or wages. GCP's costs included in selling, general and administrative expenses related to this benefit plan for the three months ended March 31, 2017 were $1.4 million , compared with GCP's allocation of the total cost related to this benefit plan for the three months ended March 31, 2016 of $1.0 million .


18


Notes to Consolidated Financial Statements (Continued)

6. Other Balance Sheet Accounts
(In millions)
March 31,
2017
 
December 31,
2016
Other Current Assets:
 
 
 
Non-trade receivables
$
19.0

 
$
19.9

Income tax receivable
18.0

 
10.6

Prepaid and other
16.1

 
12.4

Total other current assets
$
53.1

 
$
42.9

(In millions)
March 31,
2017
 
December 31,
2016
Other Current Liabilities
 
 
 
Customer volume rebates
$
21.7

 
$
30.5

Accrued compensation (1)
20.0

 
28.0

Income tax payable
5.3

 
6.7

Accrued interest
8.3

 
20.8

Pension liabilities
0.5

 
0.4

Other accrued liabilities
41.1

 
33.1

Total other current liabilities
$
96.9

 
$
119.5

________________________________
(1)  
Accrued compensation in the table above includes salaries and wages as well as estimated current amounts due under the annual and long-term incentive programs.

7. Commitments and Contingent Liabilities
Purchase Commitments     GCP uses purchase commitments to ensure supply and to minimize the volatility of certain key raw materials including lignins, polycarboxylates, amines and other materials. Such commitments are for quantities that GCP fully expects to use in its normal operations.
Guarantees and Indemnification Obligations     GCP is a party to many contracts containing guarantees and indemnification obligations. These contracts primarily consist of:
Product warranties with respect to certain products sold to customers in the ordinary course of business. These warranties typically provide that products will conform to specifications. GCP accrues a general warranty liability at the time of sale based on historical experience and on a transaction-specific basis according to individual facts and circumstances. Both the liability and annual expense related to product warranties are immaterial to the Consolidated Financial Statements.
Performance guarantees offered to customers. GCP has not established a liability for these arrangements based on past performance.
Contracts providing for the sale of a former business unit or product line in which GCP has agreed to indemnify the buyer against liabilities arising prior to the closing of the transaction, including environmental liabilities.
The Tax Sharing Agreement, which may require GCP, in certain circumstances, to indemnify Grace if the Separation, together with certain related transactions, does not qualify under Section 355 and certain other relevant provisions of the Internal Revenue Code (the "Code"). If GCP is required to indemnify Grace under the Tax Sharing Agreement, it could be subject to significant tax liabilities.

19


Notes to Consolidated Financial Statements (Continued)

Environmental Matters     GCP is subject to loss contingencies resulting from extensive and evolving federal, state, local and foreign environmental laws and regulations relating to the generation, storage, handling, discharge, disposition and stewardship of hazardous wastes and other materials. GCP accrues for anticipated costs associated with response efforts where an assessment has indicated that a probable liability has been incurred and the cost can be reasonably estimated. As of March 31, 2017 , GCP did not have any material environmental liabilities.
GCP's environmental liabilities are reassessed whenever circumstances become better defined or response efforts and their costs can be better estimated. These liabilities are evaluated based on currently available information, including the progress of remedial investigations at each site, the current status of discussions with regulatory authorities regarding the method and extent of remediation at each site, existing technology, prior experience in contaminated site remediation and the apportionment of costs among potentially responsible parties.
Financial Assurances     Financial assurances have been established for a variety of purposes, including insurance and environmental matters and other matters. At March 31, 2017 , GCP had gross financial assurances issued and outstanding of approximately $9 million , composed of standby letters of credit.
Lawsuits and Investigations      In Re: Library Gardens Balcony Litigation, Lead Case Beary v. Blackrock, Inc. Case No. RG15793054 was filed on November 12, 2015 in Alameda County Superior Court in California. It is the lead case in a consolidated lawsuit filed on behalf of six individuals who died and an additional seven individuals who were injured in a balcony collapse, which occurred on June 16, 2015 in Berkeley, California. The consolidated complaint names the Company as the sole party in the category of suppliers of materials and names twenty additional defendants in other categories, including categories for property owners, property managers, construction defendants, and development and design defendants. The consolidated complaint alleges product liability against the Company concerning one of its products. The plaintiffs seek unspecified monetary damages against all defendants and punitive damages only against the building owners, building manager and two construction company defendants. Discovery is ongoing and the trial date has been set for February 5, 2018. The Company intends to defend this action vigorously. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this matter or determine an estimate, or a range of estimates, of potential losses, if any, that might result from an adverse resolution of this matter.
In addition to the above, from time to time, GCP and its subsidiaries are parties to, or targets of, lawsuits, claims, investigations and proceedings which are managed and defended in the ordinary course of business. While GCP is unable to predict the outcome of these matters, it does not believe, based upon currently available facts, that the ultimate resolution of any of such pending matters will have a material adverse effect on its overall financial condition, results of operations or cash flows.
Accounting for Contingencies     Although the outcome of each of the matters discussed above cannot be predicted with certainty, GCP has assessed its risk and has made accounting estimates and disclosures as required under GAAP.
8. Restructuring and Repositioning Expenses
Restructuring Expenses
GCP's Board of Directors approves all major restructuring programs that may involve the discontinuance of significant product lines or the shutdown of significant facilities. From time to time, GCP takes additional restructuring actions, including involuntary terminations that are not part of a major program. GCP accounts for these costs, which are reflected in "Restructuring expenses" in its Consolidated Statements of Operations, in the period that the related liabilities are incurred. Restructuring expenses are excluded from segment operating income.
For the first quarter of 2017 , GCP incurred $1.1 million ( $0.8 million in SCC and $ 0.3 million in SBM) of restructuring expenses, which were comprised primarily of severance-related costs associated with the Separation, as well as costs related to plant closures. For the prior-year quarter, GCP incurred $0.9 million ( $0.5 million in SCC and $0.4 million in SBM) of restructuring expenses related to the Separation.

20


Notes to Consolidated Financial Statements (Continued)

GCP had restructuring liabilities of $1.6 million as of March 31, 2017 and $1.1 million as of December 31, 2016 primarily related to severance actions taken during the periods. GCP expects to pay substantially all costs related to its current restructuring programs by December 31, 2017 .
Restructuring Liability
(In millions)
Total
Balance, December 31, 2016
$
1.1

Accruals for severance
0.8

Payments
(0.3
)
Balance, March 31, 2017
$
1.6

Repositioning Expenses
Post-Separation, GCP has incurred expenses related to its transition to a stand-alone public company. The Company expects to incur these repositioning expenses, ranging from $18.0 million to $20.0 million , by the end of the second quarter of 2017. Repositioning expenses primarily relate to the following:
accounting, tax, legal and other professional costs pertaining to the Separation and establishment as a stand-alone public company;
costs relating to information technology systems and marketing expense for repackaging and re-branding;
employee-related costs that would not be incurred absent the Separation primarily relating to compensation, benefits, retention bonuses related to new or transitioning employees; and
recruitment and relocation costs associated with hiring and relocating employees.
Due to the scope and complexity of these activities, the range of estimated repositioning expenses could increase or decrease and the timing of incurrence could change.
For the three months ended March 31, 2017 , GCP incurred repositioning expenses as follows:
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Professional fees
$
1.4

 
$
2.1

Software and IT implementation fees
0.3

 

Employee-related costs
0.3

 
2.2

Total
$
2.0

 
$
4.3

GCP accounts for these costs, which are reflected in "Repositioning expenses" in the accompanying Consolidated Statements of Operations, in the period incurred. Substantially all of these costs have been or are expected to be settled in cash. Total cash payments for the three months ended March 31, 2017 were $1.1 million for repositioning expenses and $ 0.8 million for related capital expenditures.

21


Notes to Consolidated Financial Statements (Continued)

9. Other Comprehensive Income
The following tables present the pre-tax, tax and after-tax components of GCP's other comprehensive income for the three months ended March 31, 2017 and 2016 :
Three Months Ended March 31, 2017
(In millions)
Pre-Tax Amount
 
Tax (Expense)/
Benefit
 
After-Tax Amount
Currency translation adjustments
$
12.6

 

 
$
12.6

Other comprehensive income attributable to GCP shareholders
$
12.6

 
$

 
$
12.6

Three Months Ended March 31, 2016
(In millions)
Pre-Tax Amount
 
Tax (Expense)/
Benefit
 
After-Tax Amount
Defined benefit pension and other postretirement plans:
 
 
 
 
 
Amortization of net prior service cost included in net periodic benefit cost
$
(0.1
)
 
$

 
$
(0.1
)
Assumption of net prior service credit
1.2

 
(0.4
)
 
0.8

Assumption of net actuarial loss
(1.1
)
 
0.4

 
(0.7
)
Benefit plans, net

 

 

Currency translation adjustments
3.9

 

 
3.9

Loss from hedging activities
(0.2
)
 

 
(0.2
)
Other comprehensive income attributable to GCP shareholders
$
3.7

 
$

 
$
3.7

The following tables present the changes in accumulated other comprehensive income (loss), net of tax, for the three months ended March 31, 2017 and 2016 :
Three Months Ended March 31, 2017
(In millions)
Defined Benefit Pension and Other Postretirement Plans
 
Currency Translation Adjustments
 
 Gains (Losses) from Hedging Activities
 
Total
Beginning balance
$
0.1

 
$
(147.7
)
 
$

 
$
(147.6
)
Other comprehensive income before reclassifications

 
12.6

 
0.1

 
12.7

Amounts reclassified from accumulated other comprehensive income

 

 
(0.1
)
 
(0.1
)
Net current-period other comprehensive income

 
12.6

 

 
12.6

Ending balance
$
0.1

 
$
(135.1
)
 
$

 
$
(135.0
)
Three Months Ended March 31, 2016
(In millions)
Defined Benefit Pension and Other Postretirement Plans
 
Currency Translation Adjustments
 
 Gains (Losses) from Hedging Activities
 
Total
Beginning balance
$
0.1

 
$
(127.8
)
 
$

 
$
(127.7
)
Other comprehensive income (loss) before reclassifications
0.1

 
3.9

 
(0.5
)
 
3.5

Amounts reclassified from accumulated other comprehensive income (loss)
(0.1
)
 

 
0.3

 
0.2

Net current-period other comprehensive income (loss)

 
3.9

 
(0.2
)
 
3.7

Ending balance
$
0.1

 
$
(123.9
)
 
$
(0.2
)
 
$
(124.0
)

22


Notes to Consolidated Financial Statements (Continued)

GCP is a global enterprise operating in over 35 countries with local currency generally deemed to be the functional currency for accounting purposes. The currency translation adjustments reflect translation of the balance sheets valued in local currencies to the U.S. dollar as of the end of each period presented, and translation of revenues and expenses at average exchange rates for each period presented.
10. Stock Incentive Plans
GCP has provided certain key employees equity awards in the form of stock options, performance-based units (“PBUs”) and restricted share units (“RSUs”) under the GCP 2016 Stock Incentive Plan, which was adopted at Separation. Certain employees and members of the Board of Directors are eligible to receive stock-based compensation, including stock, stock options, RSUs and PBUs.
Total cash and non-cash stock-based compensation cost included in "(Loss) income from continuing operations before income taxes" on the Consolidated Statements of Operations is $2.7 million and $1.1 million for the three months ended March 31, 2017 and 2016, respectively.
During 2016, previously outstanding stock-based compensation awards granted under Grace’s equity compensation programs prior to the Separation were adjusted to reflect the impact of the Separation. To preserve the aggregate intrinsic value of those Grace awards, as measured immediately before and immediately after the Separation, each holder of Grace stock-based compensation awards generally received an adjusted award consisting of either (i) both a stock-based compensation award denominated in Grace equity as it existed subsequent to the Separation and a stock-based compensation award denominated in GCP equity or (ii) solely a stock-based compensation award denominated in the equity of the company at which the person was employed following the Separation. Adjusted awards consisting of stock-based compensation awards denominated in GCP equity are considered issued under the GCP 2016 Stock Incentive Plan. These adjusted awards generally will be subject to the same vesting conditions and other terms that applied to the original Grace awards before the Separation.
Under the Employee Matters Agreement, GCP is obligated to settle all of the stock-based compensation awards denominated in GCP equity, regardless of whether the holders are employees of GCP or Grace. Likewise, Grace is obligated to settle all of the stock-based compensation awards denominated in Grace shares, regardless of whether the holders are employees of GCP or Grace. As a result, GCP has recorded a liability for cash-settled awards held by Grace employees. The adjustment of the original Grace awards that resulted in the issuance of GCP stock-based compensation awards resulted in an immaterial charge in the first quarter of 2016.
In accordance with certain provisions of the GCP 2016 Stock Incentive Plan, GCP repurchases shares issued to certain holders of GCP awards in order to fulfill statutory tax withholding requirements for the employee. In the three months ended March 31, 2017 and 2016, GCP repurchased approximately 33,000 and 84,000 shares respectively, under these provisions. These purchases are reflected as "Treasury stock purchased under 2016 Stock Incentive Plan" in the Consolidated Statements of Equity (Deficit).
As of March 31, 2017 , 656,205 shares of common stock were available for issuance under the GCP 2016 Stock Incentive Plan.
Stock Options
Stock options are non-qualified and are set at exercise prices not less than 100% of the market value on the date of grant (market value is the average of the high price and low price from that trading day). Stock option awards that relate to Grace stock options originally granted prior to the Separation have a contractual term of five years from the original date of grant. Stock option awards granted post-Separation have a contractual term of seven or ten years from the original date of grant. Generally, stock options vest in substantially equal amounts each year over three years from the date of grant.

23


Notes to Consolidated Financial Statements (Continued)

GCP values stock options using the Black-Scholes option pricing model, which was developed for use in estimating the fair value of traded options. The risk-free rate is based on the U.S. Treasury yield curve published as of the grant date, with maturities approximating the expected term of the options. GCP estimates the expected term of the options according to the simplified method as allowed by FASB Accounting Standards Codification ("ASC") Topic No. 718-20, Awards Classified as Equity, whereby the average between the vesting period and contractual term is used. GCP estimated the expected volatility using an industry peer group.
The following summarizes GCP's assumptions for estimating the fair value of stock options granted during  2017 :
Assumptions used to calculate expense for stock option
Three Months Ended March 31, 2017
Risk-free interest rate
1.95 - 2.10%
Average life of options (years)
5.5 - 6.5
Volatility
31.42 - 31.96%
Dividend yield
Average fair value per stock option
$9.13
The following table summarizes GCP stock option activity for the three months ended March 31, 2017 :
Stock Option Activity
Number Of
Shares
(in thousands)
 
Weighted
Average Exercise
Price
 
Weighted
Average
Remaining Contractual
Term (years)
 
Aggregated
Intrinsic Value
(in thousands)
Outstanding, December 31, 2016
2,122

 
$
16.92

 
3.57
 
$
20,748

Options exercised
325

 
12.73

 

 


Options forfeited/expired/canceled
4

 
18.79

 

 


Options granted
235

 
26.40

 

 


Outstanding, March 31, 2017
2,028

 
18.69

 
4.07
 
28,863

Exercisable March 31, 2017
814

 
$
17.05

 
2.89
 
$
5,776

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between GCP's closing stock price on the last trading day of March 31, 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. The amount changes based on the fair market value of GCP's stock. The intrinsic value of all options exercised in the three-month period ended March 31, 2017 was $12.9 million .
Total unrecognized stock-based compensation expense for stock options outstanding at March 31, 2017 , was $3.0 million and the weighted-average period over which this expense will be recognized is approximately 1.2 years.
Restricted Stock Units and Performance Based Units
Upon Separation, certain previously outstanding RSUs and PBUs granted under Grace's equity compensation programs prior to the Separation were adjusted, in accordance with the Employee Matters Agreement, such that holders of these original Grace RSUs and PBUs received RSUs denominated in GCP equity.
RSUs generally vest over a three year period, with vesting in substantially equal amounts each year over three years and some vesting 100% after the third year from the date of grant. A smaller number of RSUs were designated as sign-on awards and used for purposes of attracting key employees and to cover outstanding awards from a prior employer and vest 100% after two years .

24


Notes to Consolidated Financial Statements (Continued)

GCP’s RSU activity for the three months ended March 31, 2017 is as follows:
RSU Activity
Number Of
Shares
(in thousands)
 
Weighted
Average
Grant Date
Fair Value
Outstanding, December 31, 2016
538

 
$
17.22

RSUs settled
112

 
17.17

RSUs forfeited
1

 
16.90

RSUs granted
93

 
26.34

RSUs outstanding, March 31, 2017
518

 
$
18.86

During the three months ended March 31, 2017 , GCP distributed 79,134 shares and $0.9 million of cash to settle RSUs. GCP's expectations of future RSU vesting and settlement are as follows:
Year
 
Number of Shares Vesting (in thousands)
 
Settled in Cash
 
Settled in Stock
2017
 
31
 
—%
 
100%
2018
 
197
 
10%
 
90%
2019
 
262
 
—%
 
100%
2020
 
28
 
—%
 
100%
During the three months ended March 31, 2017 , GCP granted  162,328 PBUs under the GCP 2016 Stock Incentive Plan to Company employees. These awards vest on February 2020 subject to continued employment through the payment date, and have a weighted average grant date fair value of $26.40 . PBUs that were granted during the year ended December 31, 2016 under the GCP 2016 Stock Incentive Plan to Company employees remain outstanding as of March 31, 2017 . These awards vest in February 2019 subject to continued employment through the payment date, and have a weighted average grant date fair value of $17.04 . GCP anticipates that 100%  of the PBUs will be settled in GCP common stock upon vesting. During the quarter ended March 31, 2017 , none of these awards were forfeited.
PBUs granted in 2017 are measured based on a three -year cumulative adjusted diluted earnings per share metric that is modified up or down based on relative total shareholder return performance against the Russell 3000 Index. The number of shares ultimately provided to an employee who received a 2017 PBU grant will be based on Company performance against this measure, and can range from 0% to 200% of the target number of shares granted based upon the level of achievement of this measure. The awards will be settled in 2020 once actual performance, which is measured over fiscal years 2017 - 2019 , is certified by the Compensation Committee.
PBUs and RSUs are recorded at fair value at the date of grant. The common stock-settled portion of each such award is considered an equity award, with the stock compensation expense being determined based on GCP’s stock price on the grant date. The cash settled portion of the award is considered a liability award with the liability being remeasured each reporting period based on GCP’s then current stock price. PBUs are remeasured each reporting period based on the expected payout of the award, which may range from  0%  to  200%  of the targets for such awards; therefore, these portions of the awards are subject to volatility until the payout is finally determined at the end of the performance period.
As of March 31, 2017 , $11.7 million of total unrecognized compensation expense related to the RSU and PBU awards is expected to be recognized over the remaining weighted-average service period of 1.5 years.

25


Notes to Consolidated Financial Statements (Continued)

11. Earnings Per Share
The following table shows a reconciliation of the numerators and denominators used in calculating basic and diluted (loss) earnings per share:
 
Three Months Ended March 31,
(In millions, except per share amounts)
2017
 
2016
Numerators
 
 
 
Net (loss) income from continuing operations attributable to GCP shareholders
$
(25.0
)
 
$
6.0

Income from discontinued operations, net of income taxes
$
8.1

 
$
11.8

Net (loss) income attributable to GCP shareholders
$
(16.9
)
 
$
17.8

Denominators
 
 
 
Weighted average common shares—basic calculation
71.2

 
70.6

Dilutive effect of employee stock awards

 
0.3

Weighted average common shares—diluted calculation
71.2

 
70.9

Basic (loss) earnings per share
 
 
 
Net (loss) income from continuing operations attributable to GCP shareholders
$
(0.35
)
 
$
0.08

Income from discontinued operations, net of income taxes
$
0.11

 
$
0.17

Net (loss) income attributable to GCP shareholders
$
(0.24
)
 
$
0.25

Diluted (loss) earnings per share
 
 
 
Net (loss) income from continuing operations attributable to GCP shareholders
$
(0.35
)
 
$
0.08

Income from discontinued operations, net of income taxes
$
0.11

 
$
0.17

Net (loss) income attributable to GCP shareholders
$
(0.24
)
 
$
0.25

In 2016, the computation of basic and diluted earnings per common share is calculated assuming the number of shares of GCP common stock outstanding on February 3, 2016 had been outstanding at the beginning of the period.
There were approximately 0.1 million anti-dilutive options and no anti-dilutive RSUs outstanding on a weighted-average basis for the three months ended March 31, 2017 . There were approximately 0.6 million anti-dilutive options and 0.2 million anti-dilutive RSUs outstanding on a weighted average basis for the three months ended March 31, 2016.
During the three months ended March 31, 2017 and 2016, GCP repurchased approximately 33,000 shares and 84,000 shares of Company common stock for $0.9 million and $1.7 million , respectively, in connection with its equity compensation programs.

12. Related Party Transactions and Transactions with Grace
Related Parties
All contracts with related parties are at rates and terms that GCP believes are comparable with those that could be entered into with independent third parties. Subsequent to the Separation, transactions with Grace represent third-party transactions.
Allocation of General Corporate Expenses
Prior to the Separation, the financial statements included expense allocations for certain functions provided by Grace as well as other Grace employees not solely dedicated to GCP, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, ethics and compliance, shared services, employee benefits and incentives and stock-based compensation. These expenses were allocated to GCP on the basis of direct usage when identifiable, with the remainder allocated on the basis of revenue, headcount or other measures.

26


Notes to Consolidated Financial Statements (Continued)

Between January 1, 2016 and the Separation, GCP was allocated $ 2.0 million of general corporate expense, which is primarily included within "Selling, general and administrative expenses" in the accompanying Statement of Operations for the three months ended March 31, 2016.
Transition Services Agreement
In connection with the Separation, the Company entered into a transition services agreement pursuant to which GCP and Grace provide various services to each other on a temporary, transitional basis.
The services provided by Grace to GCP include information technology, treasury, tax administration, accounting, financial reporting, human resources and other services. Following the Separation, Grace has continued to provide some of these services on a transitional basis, generally for a period of up to 18 months from the date of Separation.
Tax Sharing Agreement
The Tax Sharing Agreement governs the parties’ respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings, and other matters regarding taxes. In general, and subject to the terms of the Tax Sharing Agreement, GCP is responsible for all U.S. federal, state and foreign taxes (and any related interest, penalties or audit adjustments) reportable on a GCP separate return (a return that does not include Grace or any of its subsidiaries); and Grace is responsible for all U.S. federal, state and foreign income taxes (and any related interest, penalties or audit adjustments) reportable on a consolidated, combined or unitary return that includes Grace or any of its subsidiaries and GCP or any of its subsidiaries up to the Separation date. As of the balance sheet date, GCP has included $3.7 million of indemnified receivables in "Other assets" and $2.4 million of indemnified payables in "Other current liabilities."
In addition, the Tax Sharing Agreement imposes certain restrictions on GCP and its subsidiaries (including restrictions on share issuances, business combinations, sales of assets and similar transactions) that are designed to preserve the qualification of the Distribution, together with certain related transactions, under Section 355 and certain other relevant provisions of the Code. The Tax Sharing Agreement provides special rules that allocate tax liabilities in the event the Distribution, together with certain related transactions, does not so qualify. In general, under the Tax Sharing Agreement, each party is expected to be responsible for any taxes imposed on, and certain related amounts payable by, GCP or Grace that arise from the failure of the Distribution and certain related transactions, to qualify under Section 355 and certain other relevant provisions of the Code, to the extent that the failure to so qualify is attributable to actions, events or transactions relating to such party’s respective stock, assets or business, or a breach of the relevant representations or covenants made by such party in the Tax Sharing Agreement.
Parent Company Equity
Net transfers to parent are included within net parent investment on the Consolidated Statements of (Deficit) Equity. The components of the net transfers to parent as of March 31, 2016 are as follows:
(In millions)
2016
Cash pooling and general financing activities
$
(690.8
)
GCP expenses funded by parent
6.6

Corporate costs allocations
2.0

Provision for income taxes
4.3

Total net transfers to parent
(677.9
)
Other, net
(80.8
)
Transfers to parent, net, per Consolidated Statement of Cash Flows
$
(758.7
)
In the three months ended March 31, 2017, there were no adjustments to parent company equity. In 2016, "Other, net" includes the non-cash transfer from parent of approximately $44 million of net pension liabilities, approximately $23 million of fixed assets and the non-cash transfer of approximately $36 million of related-party debt, deferred tax items and other items.

27


Notes to Consolidated Financial Statements (Continued)

As discussed in Note 3, GCP used proceeds from the Notes and Credit Facilities to fund a distribution to Grace in an amount of $750.0 million related to the Separation. This distribution is reflected as a component of transfers to parent in the table above.
13. Operating Segment Information
GCP is engaged in the production and sale of specialty construction chemicals and specialty building materials through two operating segments. Specialty Construction Chemicals manufactures and markets concrete admixtures and cement additives. Specialty Building Materials manufactures and markets sheet and liquid membrane systems that protect structures from water, air and vapor penetration, fireproofing, and other products designed to protect the building envelope.
The table below presents information related to GCP's operating segments. Only those corporate expenses directly related to the operating segments are allocated for reporting purposes. GCP excludes certain functional costs, impacts of foreign exchange (related primarily to Venezuela) and other corporate costs such as certain performance-based incentive compensation and public company costs from segment operating income. GCP also excludes certain ongoing defined benefit pension costs recognized quarterly, which include service and interest costs, the effect of expected returns on plan assets and amortization of prior service costs/credits, from the calculation of segment operating income. GCP believes that the exclusion of certain corporate costs and pension costs provides a better indicator of its operating segment performance as such costs are not managed at an operating segment level.
Operating Segment Data
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Net Sales
 
 
 
Specialty Construction Chemicals
$
134.0

 
$
137.0

Specialty Building Materials
91.3

 
100.7

Total
$
225.3

 
$
237.7

Segment Operating Income
 
 
 
Specialty Construction Chemicals segment operating income
$
8.6

 
$
9.9

Specialty Building Materials segment operating income
15.2

 
27.8

Total segment operating income
$
23.8

 
$
37.7


28


Notes to Consolidated Financial Statements (Continued)

Reconciliation of Operating Segment Data to Financial Statements
Total segment operating income for the three months ended March 31, 2017 and 2016 , is reconciled below to "(Loss) income from continuing operations before income taxes" presented in the accompanying Consolidated Statements of Operations:
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Total segment operating income
$
23.8

 
$
37.7

Corporate costs (1)
(10.2
)
 
(7.7
)
Certain pension costs
(2.6
)
 
(1.9
)
Repositioning expenses
(2.0
)
 
(4.3
)
Restructuring expenses
(1.1
)
 
(0.9
)
Pension MTM adjustment and other related costs, net

 
(2.7
)
Third-party acquisition-related costs
(0.4
)
 

Amortization of acquired inventory fair value adjustment
(1.5
)
 

Tax indemnification adjustments
(2.4
)
 

Net income attributable to noncontrolling interests

 
0.4

Interest expense, net
(17.0
)
 
(12.5
)
(Loss) income from continuing operations before income taxes
$
(13.4
)
 
$
8.1

_______________________________
(1)  
Corporate costs include approximately $3.0 million and $1.6 million of allocated costs in the three months ended March 31, 2017 and 2016, respectively, that were previously reported within the Darex operating segment. Such costs did not qualify to be reclassified to discontinued operations.
Geographic Area Data
The table below presents information related to the geographic areas in which GCP operates. Sales are attributed to geographic areas based on customer location.
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Net Sales
 
 
 
United States
$
106.8

 
$
106.0

Canada and Puerto Rico
5.1

 
6.6

Total North America
111.9

 
112.6

Europe Middle East Africa
45.5

 
55.1

Asia Pacific
51.2

 
54.9

Latin America
16.7

 
15.1

Total
$
225.3

 
$
237.7


29


Notes to Consolidated Financial Statements (Continued)

14. Discontinued Operations
As discussed in Note 1, on March 2, 2017, the Company entered into the Offer Letter with Henkel, pursuant to which Henkel made a binding offer (the "Offer") to acquire Darex for approximately  $1.05 billion , subject to working capital and certain other adjustments. Pursuant to the terms of the Offer Letter, following the conclusion of statutory employee consultation processes in connection with the Acquisition by the relevant works councils in France, the Company accepted Henkel’s offer and countersigned the Purchase Agreement with respect to the Acquisition, which was previously executed by Henkel, on April 28, 2017. Completion of the Acquisition remains subject to the satisfaction or waiver of customary closing conditions, including regulatory approvals. The Company has received antitrust clearances in the United States, Germany, Brazil, Russia and Austria and has filed for antitrust clearance in South Africa. The Acquisition is expected to close in the middle of 2017.
In accordance with applicable accounting guidance for the disposal of long-lived assets, Darex met the criteria to be classified as held for sale in the first quarter of 2017. As such, the assets and liabilities related to Darex have been reclassified and reflected as "held for sale" on the Consolidated Balance Sheets for all periods presented. Additionally, Darex has been reclassified and reflected as "discontinued operations" on the Consolidated Statements of Operations and Consolidated Statements of Cash Flows for all periods presented.
In connection with the Offer, the Company and Henkel also entered into a Transition Services Agreement pursuant to which Henkel and the Company will provide various services to each other in connection with the transition of the Darex business to Henkel. These services are expected to be performed for various periods up to 24 months following the closing date and include real estate, information technology, accounts payable, payroll, and other financial functions and administrative services. The agreed upon charges for such services will be generally intended to allow the servicing party to recover all out-of-pocket costs and expenses of providing such services.
Additionally, in connection with the Offer, the Company and Henkel entered into a Master Tolling Agreement, whereby Henkel will operate certain equipment at facilities being sold to manufacture and prepare for shipping certain products related to product lines that will continue to be owned by the Company. These services are expected to be provided for a period of 24 months following the closing date, which can be further extended at that time.
"Income from discontinued operations, net of income taxes" in the accompanying Statements of Operations is comprised of the following:
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Net sales
$
71.8

 
$
76.4

Cost of goods sold
45.2

 
48.4

Selling, general and administrative expenses
14.8

 
7.9

Research and development expenses
1.1

 
1.2

Other non-operating income, net
0.8

 
1.2

Provision for income taxes
(1.8
)
 
(5.9
)
Income from discontinued operations, net of income taxes
$
8.1

 
$
11.8







30


Notes to Consolidated Financial Statements (Continued)

The carrying amounts of the major classes of assets and liabilities of Darex classified as "held for sale" as of March 31, 2017 and December 31, 2016 consist of the following:
(In millions)
March 31, 2017
 
December 31, 2016
Cash and cash equivalents
$
22.3

 
$
17.2

Trade accounts receivable
48.1

 
50.5

Inventories
38.7

 
32.3

Other current assets
9.2

 
8.9

Current assets held for sale
118.3

 
108.9

Properties and equipment, net
41.0

 
40.0

Goodwill
4.7

 
4.4

Technology and other intangible assets, net
0.4

 
0.4

Deferred income taxes
7.9

 
6.4

Other assets
4.6

 
4.6

Noncurrent assets held for sale
58.6

 
55.8

Accounts payable
33.3

 
27.2

Other current liabilities
19.4

 
21.5

Current liabilities held for sale
52.7

 
48.7

Deferred income taxes
2.4

 
2.3

Underfunded and unfunded defined benefit pension plans
15.6

 
14.8

Other liabilities
3.5

 
3.8

Noncurrent liabilities held for sale
$
21.5

 
$
20.9

15. Subsequent Events
On May 8, 2017, GCP announced that it has signed a definitive agreement to acquire U.K.-based Stirling Lloyd for approximately $94 million in cash. The Company expects to fund the acquisition, in part, by drawing on its available credit facilities. Stirling Lloyd is a supplier of high-performance liquid waterproofing and coatings products with annual net sales of approximately $40 million . The Company expects to complete the transaction, which is subject to local regulatory approvals, in the second quarter of 2017.
On May 3, 2017, the Board of Directors approved an amendment to the Company's U.S. Salaried Pension Plan that closes the plan to new hires effective January 1, 2018 and freezes the accrual of plan benefits for all plan participants as of December 31, 2022. Management expects to recognize in 2017 a curtailment gain in the range of $4 million to $6 million as a result of this plan amendment.


31



ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
We generally refer to the quarter ended March 31, 2017 , as the " first quarter ," the quarter ended March 31, 2016 , as the "prior-year quarter." See Analysis of Operations for a discussion of our non-GAAP performance measures.
On March 2, 2017, GCP announced the sale of Darex to Henkel. The results of operations of the Darex segment are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. Unless otherwise noted, the following discussion and analysis pertains only to our continuing operations.
Results of Operations
Summary Description of Business
We are engaged in the production and sale of specialty construction chemicals and specialty building materials through two operating segments:
Specialty Construction Chemicals. Specialty Construction Chemicals ("SCC") provides products, technologies, and services that reduce the cost and improve the performance of cement, concrete, mortar, masonry and other cementitious based construction materials.
Specialty Building Materials. Specialty Building Materials ("SBM") produces and sells sheet and liquid membrane systems and other products that protect both new and existing structures from water, air, and vapor penetration, and from fire damage. We also manufacture and sell specialized cementitious and chemical grouts used for soil consolidation and leak-sealing applications.
We operate our business on a global scale with approximately 54.4% of our annual 2016 net sales from outside the United States. We conduct business in over 35 countries in over 30 currencies. We manage our operating segments on a global basis, to serve global markets. Currency fluctuations affect our reported results of operations, cash flows, and financial position.
On January 27, 2016, GCP entered into a separation and distribution agreement pursuant to which W.R. Grace & Co. ("Grace") agreed to transfer its Grace Construction Products operating segment and the packaging technologies business, operated under the “Darex” name, of its Grace Materials Technologies operating segment to GCP (the "Separation"). The Separation occurred on February 3, 2016, by means of a pro rata distribution to Grace stockholders of all of the then-outstanding shares of Company common stock, at which time GCP became an independent public company and its common stock listed and began trading under the symbol "GCP" on the New York Stock Exchange.
First Quarter Performance Summary
Following is a summary of our financial performance for the first quarter compared with the prior-year quarter.
Net sales decrease d 5.2% to $225.3 million .
Net loss from continuing operations attributable to GCP shareholders was $25.0 million or $0.35 per diluted share, compared to net income from continuing operations attributable to GCP shareholders of $6.0 million or $0.08 per diluted share, for the prior-year quarter. Adjusted EPS was $(0.06) per diluted share compared to $0.15 in the prior-year quarter.
Adjusted EBIT decrease d 60.9% to $11.0 million .
Adjusted EBIT Return On Invested Capital was 25.9% on a trailing four quarters basis compared with 37.2% for the 2016 first quarter .

32


Table of Contents

Analysis of Operations
We have set forth in the table below our key operating statistics with percentage changes for the first quarter and three months compared with the corresponding prior-year quarter. Please refer to this Analysis of Operations (the “table”) when reviewing our Management's Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”). In the table, we present financial information in accordance with U.S. GAAP, as well as certain non-GAAP financial measures, which we describe below in further detail. We believe that the non-GAAP financial information supplements our discussions about the performance of our businesses, improves quarter-to-quarter comparability and provides insight to the information that our management uses to evaluate the performance of our businesses. Our management uses non-GAAP measures in financial and operational decision-making processes, for internal reporting, and as part of forecasting and budgeting processes, as these measures provide additional transparency to our core operations.
In the table, we have provided reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP. These non-GAAP financial measures should not be considered substitutes for financial measures calculated in accordance with U.S. GAAP, and the financial results that we calculate and present in the table in accordance with U.S. GAAP, as well as the corresponding reconciliations from those results, should be carefully evaluated as part of our MD&A.
We define Adjusted EBIT (a non-GAAP financial measure) to be net income from continuing operations attributable to GCP shareholders adjusted for interest income; interest expense and related financing costs; income taxes; restructuring and repositioning expenses and asset impairments; pension costs other than service and interest costs, expected returns on plan assets and amortization of prior service costs/credits; income and expense items related to certain product lines and investments; gains and losses on sales of businesses, product lines and certain other investments; third-party acquisition-related costs; the amortization of acquired inventory fair value adjustment; tax indemnification adjustments; and certain other items that are not representative of underlying trends. We use Adjusted EBIT to assess and measure our operating performance and in determining performance-based compensation. We use Adjusted EBIT as a performance measure because it provides improved quarter-to-quarter comparability for decision-making and compensation purposes and because it allows management to measure the ongoing earnings results of our strategic and operating decisions.
We define Adjusted EBITDA (a non-GAAP financial measure) to be Adjusted EBIT adjusted for depreciation and amortization. We use Adjusted EBITDA as a performance measure in making significant business decisions.
We define Adjusted Earnings Per Share (a non-GAAP financial measure) to be earnings per share ("EPS") from continuing operations on a diluted basis adjusted for costs related to restructuring and repositioning expenses and asset impairments; pension costs other than service and interest costs, expected return on plan assets and amortization of prior service costs/credits; gains and losses on sales of businesses, product lines and certain other investments; third-party acquisition-related costs; other financing costs associated with the modification or extinguishment of debt; certain other items that are not representative of underlying trends; and certain discrete tax items. We use Adjusted EPS as a performance measure to review our diluted earnings per share results on a consistent basis.
We define Adjusted Gross Profit (a non-GAAP financial measure) to be gross profit adjusted for pension-related costs. Adjusted Gross Margin means Adjusted Gross Profit divided by net sales. We use this performance measure to understand trends and changes and to make business decisions regarding core operations.
We define Adjusted EBIT Return On Invested Capital (a non-GAAP financial measure) to be Adjusted EBIT (on a trailing four quarters basis) divided by the sum of net working capital, properties and equipment and certain other assets and liabilities. We use Adjusted EBIT Return On Invested Capital as a performance measure to review investments and to make capital allocation decisions.
Adjusted EBIT, Adjusted EBITDA, Adjusted EPS, Adjusted EBIT Return On Invested Capital and Adjusted Gross Margin do not purport to represent income measures as defined under U.S. GAAP. These measures are provided to investors and others to improve the quarter-to-quarter comparability and peer-to-peer comparability of our financial results and to ensure that investors understand the information we use to evaluate the performance of our businesses.

33


Table of Contents

Adjusted EBIT has material limitations as an operating performance measure because it excludes costs related to income and expenses from restructuring and repositioning activities, which historically has been a material component of our net income. Adjusted EBITDA also has material limitations as an operating performance measure because it excludes the impact of depreciation and amortization expense. Our business is substantially dependent on the successful deployment of capital, and depreciation and amortization expense is a necessary element of our costs. We compensate for the limitations of these measurements by using these indicators together with net income as measured under GAAP to present a complete analysis of our results of operations. Adjusted EBIT and Adjusted EBITDA should be evaluated together with net income measured under GAAP for a complete understanding of our results of operations.


34


Table of Contents

We have provided in the following tables a reconciliation of these non-GAAP measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.
Analysis of Operations
(In millions, except per share amounts)
Three Months Ended March 31,
2017
 
2016
 
% Change
Net sales:
 
 
 
 
 
Specialty Construction Chemicals
$
134.0

 
$
137.0

 
(2.2
)%
Specialty Building Materials
91.3

 
100.7

 
(9.3
)%
Total GCP net sales
$
225.3

 
$
237.7

 
(5.2
)%
Net sales by region:
 
 
 
 
 
North America
$
111.9

 
$
112.6

 
(0.6
)%
Europe Middle East Africa (EMEA)
45.5

 
55.1

 
(17.4
)%
Asia Pacific
51.2

 
54.9

 
(6.7
)%
Latin America
16.7

 
15.1

 
10.6
 %
Total net sales by region
$
225.3

 
$
237.7

 
(5.2
)%
Profitability performance measures:
 
 
 
 
 
Adjusted EBIT(A):
 
 
 
 
 
Specialty Construction Chemicals segment operating income
$
8.6

 
$
9.9

 
(13.1
)%
Specialty Building Materials segment operating income
15.2

 
27.8

 
(45.3
)%
Corporate costs(B)
(10.2
)
 
(7.7
)
 
(32.5
)%
Certain pension costs(C)
(2.6
)
 
(1.9
)
 
(36.8
)%
Adjusted EBIT (non-GAAP)
11.0

 
28.1

 
(60.9
)%
Repositioning expenses
(2.0
)
 
(4.3
)
 
53.5
 %
Restructuring expenses
(1.1
)
 
(0.9
)
 
(22.2
)%
Pension MTM adjustment and other related costs, net

 
(2.7
)
 
NM

Third-party acquisition-related costs
(0.4
)
 

 
NM

Amortization of acquired inventory fair value adjustment
(1.5
)
 

 
NM

Tax indemnification adjustments
(2.4
)
 

 
NM

Interest expense, net
(17.0
)
 
(12.5
)
 
36.0
 %
Provision for income taxes
(11.6
)
 
(1.7
)
 
NM

Net (loss) income from continuing operations attributable to GCP shareholders (GAAP)
$
(25.0
)
 
$
6.0

 
NM

Diluted EPS from continuing operations (GAAP)
$
(0.35
)
 
$
0.08

 
NM

Adjusted EPS (non-GAAP)
$
(0.06
)
 
$
0.15

 
NM


35


Table of Contents

Analysis of Operations
(In millions)
Three Months Ended March 31,
2017
 
2016
 
% Change
Adjusted profitability performance measures:
 

 
 

 
 

Gross Profit:
 

 
 

 
 

Specialty Construction Chemicals
$
47.8

 
$
47.1

 
1.5
 %
Specialty Building Materials
39.5

 
46.6

 
(15.2
)%
Adjusted Gross Profit (non-GAAP)
87.3

 
93.7

 
(6.8
)%
Amortization of acquired inventory fair value adjustment
(1.5
)
 

 
NM

Pension costs in cost of goods sold
(0.5
)
 
(0.3
)
 
(66.7
)%
Total GCP Gross Profit (GAAP)
85.3

 
93.4

 
(8.7
)%
Gross Margin:
 

 
 

 
 

Specialty Construction Chemicals
35.7
 %
 
34.4
 %
 
1.3 pts
Specialty Building Materials
43.3
 %
 
46.3
 %
 
(3.0) pts
Adjusted Gross Margin (non-GAAP)
38.7
 %
 
39.4
 %
 
(0.7) pts
Amortization of acquired inventory fair value adjustment
(0.7
)%
 
 %
 
NM

Pension costs in cost of goods sold
(0.2
)%
 
(0.1
)%
 
(0.1) pts
Total GCP Gross Margin (GAAP)
37.8
 %
 
39.3
 %
 
(1.5) pts
Adjusted EBIT(A)(B)(C):
 

 
 

 
 

Specialty Construction Chemicals segment operating income
$
8.6

 
$
9.9

 
(13.1
)%
Specialty Building Materials segment operating income
15.2

 
27.8

 
(45.3
)%
Corporate and certain pension costs
(12.8
)
 
(9.6
)
 
(33.3
)%
Total GCP Adjusted EBIT (non-GAAP)
11.0

 
28.1

 
(60.9
)%
Depreciation and amortization:
 

 
 

 
 

Specialty Construction Chemicals
$
5.1

 
$
4.8

 
6.3
 %
Specialty Building Materials
2.9

 
2.2

 
31.8
 %
Corporate
0.4

 
0.4

 
 %
Total GCP
8.4

 
7.4

 
13.5
 %
Adjusted EBITDA:
 

 
 

 
 

Specialty Construction Chemicals
$
13.7

 
$
14.7

 
(6.8
)%
Specialty Building Materials
18.1

 
30.0

 
(39.7
)%
Corporate and certain pension costs
(12.4
)
 
(9.2
)
 
(34.8
)%
Total GCP Adjusted EBITDA (non-GAAP)
19.4

 
35.5

 
(45.4
)%
Adjusted EBIT Margin:
 

 
 

 
 

Specialty Construction Chemicals
6.4
 %
 
7.2
 %
 
(0.8) pts
Specialty Building Materials
16.6
 %
 
27.6
 %
 
(11.0) pts
Total GCP Adjusted EBIT Margin (non-GAAP)
4.9
 %
 
11.8
 %
 
(6.9) pts
Adjusted EBITDA Margin:
 

 
 

 
 

Specialty Construction Chemicals
10.2
 %
 
10.7
 %
 
(0.5) pts
Specialty Building Materials
19.8
 %
 
29.8
 %
 
(10.0) pts
Total GCP Adjusted EBITDA Margin (non-GAAP)
8.6
 %
 
14.9
 %
 
(6.3) pts


36


Table of Contents

Analysis of Operations
(In millions)
Four Quarters Ended
March 31, 2017
 
March 31, 2016
Calculation of Adjusted EBIT Return On Invested Capital (trailing four quarters):
Adjusted EBIT
$
125.3

 
$
157.9

Invested Capital:
 

 
 

Trade accounts receivable
169.4

 
168.4

Inventories
101.3

 
79.2

Accounts payable
(104.7
)
 
(93.3
)
 
166.0

 
154.3

Other current assets (excluding income taxes and related party loans receivable)
35.0

 
24.0

Properties and equipment, net
191.5

 
182.1

Goodwill
115.1

 
99.7

Technology and other intangible assets, net
51.0

 
32.7

Investment in unconsolidated affiliate

 

Other assets (excluding capitalized financing fees)
19.7

 
17.2

Other current liabilities (excluding income taxes, restructuring, repositioning and accrued interest)
(81.4
)
 
(76.2
)
Other liabilities (excluding other postretirement benefits liability)
(13.8
)
 
(9.1
)
Total invested capital
$
483.1

 
$
424.7

Adjusted EBIT Return On Invested Capital (non-GAAP)
25.9
%
 
37.2
%
___________________________________________________________________________________________________________________
Amounts may not add due to rounding.
(A)
GCP's segment operating income includes only GCP's share of income of consolidated joint ventures.
(B)
Management allocates all costs within corporate to each segment to the extent such costs are directly attributable to the segments. Corporate costs include approximately $3.0 million and $1.6 million of allocated costs in the three months ended March 31, 2017 and 2016, respectively, that were previously reported within the Darex operating segment. Such costs did not qualify to be reclassified to discontinued operations.
(C)
Certain pension costs include only ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits. Other pension related costs including annual mark-to-market adjustments, actuarial gains and losses, gains or losses from curtailments and terminations, and other related costs are excluded from Adjusted EBIT. These amounts are not used by management to evaluate the performance of the GCP businesses and significantly affect the peer-to-peer and quarter-to-quarter comparability of our financial results. Mark-to-market adjustments, actuarial gains and losses, and other related costs relate primarily to changes in financial market values and actuarial assumptions and are not directly related to the operation of the GCP businesses. SCC and SBM segment operating income and corporate costs do not include any amounts for pension cost.
NM
Not meaningful.

37


Table of Contents

Adjusted EPS
The following table reconciles our Diluted EPS (GAAP) to our Adjusted EPS (non-GAAP):
 
Three Months Ended March 31,
 
2017
 
2016
(In millions, except per share amounts)
Pre-
Tax
 
Tax Effect
 
After-
Tax
 
Per
Share
 
Pre-
Tax
 
Tax Effect
 
After-
Tax
 
Per
Share
Diluted EPS from continuing operations (GAAP)
 

 
 

 
 

 
$
(0.35
)
 
 

 
 

 
 

 
$
0.08

Repositioning expenses
$
2.0

 
$
0.8

 
$
1.2

 
0.02

 
$
4.3

 
$
1.7

 
$
2.6

 
0.04

Restructuring expenses
1.1

 
0.3

 
0.8

 
0.01

 
0.9

 
0.3

 
0.6

 
0.01

Pension MTM adjustment and other related costs, net

 

 

 

 
2.7

 
1.0

 
1.7

 
0.02

Third-party acquisition-related costs
0.4

 
0.2

 
0.2

 

 

 

 

 

Amortization of acquired inventory fair value adjustment
1.5

 
0.6

 
0.9

 
0.01

 

 

 

 

Tax indemnification adjustments
2.4

 
0.9

 
1.5

 
0.02

 

 

 

 

Discrete tax items:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discrete tax items, including adjustments to uncertain tax positions

 
(16.7
)
 
16.7

 
0.23

 

 
(0.1
)
 
0.1

 

Adjusted EPS (non-GAAP)
 
 
 
 
 
 
$
(0.06
)
 
 

 
 

 
 

 
$
0.15

GCP Overview
Following is an overview of our financial performance for the first quarter compared with the prior-year quarter.
Net Sales and Gross Margin
A2017Q110-Q_CHARTX10584.JPG
The following table identifies the year-over-year increase or decrease in sales attributable to changes in volume and/or mix, product price, and the impact of currency translation for the quarter.

38


Table of Contents

 
Three Months Ended March 31, 2017
as a Percentage Increase (Decrease) from
Three Months Ended March 31, 2016
Net Sales Variance Analysis
Volume
 
Price
 
Currency Translation
 
Total Change
Specialty Construction Chemicals
(3.2
)%
 
7.3
 %
 
(6.3
)%
 
(2.2
)%
Specialty Building Materials
(9.7
)%
 
1.8
 %
 
(1.4
)%
 
(9.3
)%
Net sales
(5.9
)%
 
5.0
 %
 
(4.3
)%
 
(5.2
)%
By Region:
 
 
 
 
 
 
 
North America
(2.0
)%
 
1.2
 %
 
0.2
 %
 
(0.6
)%
Europe Middle East Africa
(12.8
)%
 
1.0
 %
 
(5.6
)%
 
(17.4
)%
Asia Pacific
(4.8
)%
 
(1.5
)%
 
(0.4
)%
 
(6.7
)%
Latin America
(14.2
)%
 
71.2
 %
 
(46.4
)%
 
10.6
 %
Net sales of $225.3 million for the first quarter of 2017 decrease d $12.4 million or 5.2% compared with the prior-year quarter. The decrease was primarily due to lower sales volumes across all regions and the negative impact of foreign exchange in Latin America, EMEA and Asia Pacific, as the U.S. dollar strengthened against the majority of the foreign currencies in which we transact business. Price increases in both SCC and SBM partially offset the declines in sales volume and negative impacts of foreign exchange, especially in Latin America, which was driven by hyper-inflation in Venezuela.
GCP's gross margin of 37.8% decrease d 150 basis points for the first quarter compared with the prior-year quarter, primarily due to lower gross margin in SBM and the impact of an inventory fair value adjustment relating to the Halex acquisition, partially offset by higher gross margin in SCC. GCP's Adjusted Gross Margin of 38.7% decrease d 70 basis points for the first quarter compared with the prior-year quarter as a result of lower gross margin in SBM, partially offset by improved gross margin in SCC.
Net Income (Loss) Attributable to GCP Shareholders
A2017Q110-Q_CHARTX11576.JPG
Net loss from continuing operations attributable to GCP shareholders was $25.0 million for the first quarter of 2017 , compared to net income from continuing operations attributable to GCP shareholders of $6.0 million for the prior-year quarter. The change was primarily due to higher income taxes, interest expense, selling, general and administrative expenses and lower gross profit, partially offset by lower repositioning expenses. Selling, general, and administrative expenses increased primarily due to the acquisition of Halex in the fourth quarter of 2016, and higher employee-related costs, corporate facility costs, and professional fees as the Company built out its corporate and global support functions throughout 2016 as part of the Separation.

39


Table of Contents

Adjusted EBIT
A2017Q110-Q_CHARTX12549.JPG
Adjusted EBIT was $11.0 million for the first quarter of 2017, a decrease of 60.9% compared with the prior-year quarter. The decrease was primarily due to lower Adjusted Gross Profit and higher selling, general and administrative expenses.
Adjusted EBIT Return On Invested Capital
A2017Q110-Q_CHARTX13721.JPG
Adjusted EBIT Return On Invested Capital for the first quarter decrease d to 25.9% on a trailing four quarters basis from 37.2% on the same basis for the prior-year quarter. The decrease was mainly driven by a decline in the trailing four quarters of Adjusted EBIT and a 13.8% increase in invested capital that resulted primarily from the acquisition of Halex in the fourth quarter of 2016.
We manage our operations with the objective of maximizing sales, earnings and cash flow over time. Doing so requires that we successfully balance our growth, profitability and working capital and other investments to support sustainable, long-term financial performance. We use Adjusted EBIT Return On Invested Capital as a performance measure in evaluating operating results, in making operating and investment decisions and in balancing the growth and profitability of our operations. Generally, we favor those businesses and investments that provide the highest return on invested capital.


40


Table of Contents


Operating Segment Overview—Specialty Construction Chemicals (SCC)
Following is an overview of the financial performance of SCC for the first quarter compared with the corresponding prior-year quarter.
Net Sales—SCC
A2017Q110-Q_CHARTX09936.JPG
Net sales were $134.0 million for the first quarter , a decrease of 2.2% compared with the prior-year quarter. The decrease in net sales was due primarily to unfavorable foreign exchange rates and volume declines in Asia, Europe and Latin America, partially offset by volume increases in North America and inflation-driven price increases in Venezuela.
Sales volumes declined in our Concrete business by 4.7% , with increases in North America offset by the continued impact of geopolitical events in Turkey, a slow-down in the Middle East, lower demand in Latin America and year-over-year declines in Asia Pacific. Sales volumes increased 1.9% in our Cement business, with growth across all regions.
Currency translation had an unfavorable impact primarily in Latin America and Europe, with Latin America reflecting currency declines in Venezuela.


41


Table of Contents

Segment Operating Income (SOI) and Margin—SCC
A2017Q110-Q_CHARTX11308.JPG
Gross profit was $47.8 million for the first quarter , an increase of $0.7 million or 1.5% compared with the prior-year quarter. Gross margin was 35.7% , compared with 34.4% for the prior-year quarter, with pricing and productivity gains partially offset by increases in raw material costs.
Segment operating income was $8.6 million for the first quarter , a decrease of $1.3 million or 13.1% compared with the prior-year quarter. Segment operating margin decrease d 80 basis points to 6.4% compared with the prior-year quarter, primarily due to investments in research and development and higher general and administrative expenses.

42


Table of Contents

Operating Segment Overview—Specialty Building Materials (SBM)
Following is an overview of the financial performance of SBM for the first quarter compared with the corresponding prior-year quarter.
Net Sales—SBM
A2017Q110-Q_CHARTX09972.JPG
Net sales were $91.3 million for the first quarter , a decrease of 9.3% compared with the prior-year quarter including $8.4 million , or 8.3% of sales growth, from Halex. The decrease was due to lower sales volumes and unfavorable currency translation, which more than offset higher pricing. Net sales increased in Specialty Construction Products by 28.8% but decreased in Building Envelope and Residential by 20.6% and 18.4% , respectively. Specialty Construction Products included 38% growth from Halex . Product line sales volumes decreased in all regions ( 5.9% in North America, 6.1% in Asia Pacific, 18.4% in Europe and 60.4% in Latin America). The decrease in North America was driven by a difficult comparison with the prior year due to abnormally mild winter weather in 2016 as well as project timing. The sales volume decrease in both Europe and Asia Pacific was a result of large infrastructure projects completed in the comparable prior-year quarter .
Currency translation had an unfavorable impact in Europe and Asia Pacific and price improved in North America and Europe.


43


Table of Contents

Segment Operating Income (SOI) and Margin—SBM
A2017Q110-Q_CHARTX11528.JPG
Gross profit was $39.5 million for the first quarter , a decrease of 15.2% from the prior-year quarter. Gross margin was 43.3% compared with 46.3% for the prior-year quarter primarily due to Halex, which has gross margins that are below the average segment margin. The balance of the decrease was primarily due to increased raw material inflation, lower volumes and unfavorable product mix, partially offset by increased pricing and productivity.
Segment operating income was $15.2 million for the first quarter , a decrease of 45.3% from the prior-year quarter. Segment operating margin for the first quarter was 16.6% , a decrease from 27.6% in the prior-year quarter. The decrease resulted from lower gross margin and higher selling, general and administrative costs, primarily due to the addition of Halex and higher employee-related costs.

44


Table of Contents

Corporate Overview
A2017Q110-Q_CHARTX09738.JPG
Corporate costs include certain functional costs, impacts of foreign exchange and other corporate costs such as certain performance-based incentive compensation and public company costs that are not allocated to our operating segments. Corporate costs were $10.2 million for the first quarter , an increase of 32.5% compared with the prior-year quarter. The increase was primarily due to higher global functional costs and increased stock-based compensation expense, which was partially due to accelerated vesting of certain awards.
Defined Benefit Pension Expense
Certain pension costs for the first quarter were $2.6 million compared with $1.9 million for the corresponding prior-year quarter. The increase relates primarily to lower discount rates and demographic factors related to plan participants.
Pension mark-to-market and other related costs, net, were $2.7 million in the prior-year quarter, primarily due to a $2.4 million liability recorded relating to a U.S. multi-employer plan that GCP participants withdrew from during the years 2007 to 2011, triggering a partial withdrawal under ERISA rules.
Restructuring and Repositioning Expenses
GCP incurred $1.1 million of restructuring expenses during the first quarter ended March 31, 2017 , compared with $0.9 million for the prior-year quarter. The increase was primarily due to higher severance costs incurred as a result of the Separation.
Post-Separation, GCP has incurred expenses related to the transition to becoming a stand-alone public company. These costs are expected to range from $18.0 million to $20.0 million , of which $ 17.2 million has been incurred through March 31, 2017 . We expect to incur substantially all of these expenses by the end of the second quarter of 2017. Repositioning expenses for the three months ended March 31, 2017 and 2016 were as follows:
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Professional fees
$
1.4

 
$
2.1

Software and IT implementation fees
0.3

 

Employee-related costs
0.3

 
2.2

Total
$
2.0

 
$
4.3

We exclude restructuring and repositioning expenses from Adjusted EBIT.

45


Table of Contents

Interest and Financing Expenses
Net interest and financing expenses were $ 17.0 million for the first quarter of 2017 compared to $12.5 million in the corresponding prior-year quarter, an increase of 36.0% . The increase resulted primarily from the February 2016 issuance of our debt, for which we did not incur a full quarterly period of interest expense.
Income Taxes
The income tax provision on continuing operations at the U.S. federal corporate rate of 35% for the first quarter and the prior-year quarter would have been $(4.7) million and $2.8 million , respectively. The differences between these amounts and the recorded provision for income taxes of $11.6 million and $1.7 million , respectively, resulted primarily from the recording of a valuation allowance against U.S., Brazil, and Turkey deferred tax assets and against U.S. foreign tax credit carryovers, which resulted in an increase to the effective rate in the first quarter of 2017 of 103.0 percentage points, as well as a change in the Company’s assertion that it is indefinitely reinvested in Mexico, as discussed further below, which added 14.2 percentage points. Our effective tax rate may change over time as the amount or mix of income and taxes changes among the jurisdictions in which we are subject to tax. The foreign rate differential in the first quarter of 2017 and 2016 resulted in decreases to the annualized effective tax rate of 5.2 and 7.4 percentage points, respectively.
For the three months ended March 31, 2017 and 2016, GCP recorded income tax expense on discontinued operations of $1.8 million and $5.9 million , respectively. Refer to Note 14 for further details.
As of December 31, 2016, GCP had the intent and ability to indefinitely reinvest undistributed earnings of its foreign subsidiaries outside the United States. During the first quarter of 2017, GCP determined it could no longer assert it is indefinitely reinvested in Mexico because that entity is anticipated to be sold as part of the Darex transaction. The tax associated with its outside book and tax basis difference in Mexico was recorded during the quarter as a discrete item resulting in a tax expense of $1.9 million . GCP believes that the anticipated sale of Darex is a one-time, non-recurring event and that recognition of deferred taxes of undistributed earnings during 2017 would not have occurred if not for the anticipated sale. As of March 31, 2017 , GCP has the intent and ability to indefinitely reinvest undistributed earnings of all its other foreign subsidiaries outside the United States. Subsequent to the anticipated sale of Darex, GCP expects undistributed prior-year earnings of its foreign subsidiaries to remain indefinitely reinvested except in certain instances where repatriation of such earnings would result in minimal or no tax. GCP bases this assertion on:

(1)
the expectation that it will satisfy its U.S. cash obligations in the foreseeable future without requiring the repatriation of prior-year foreign earnings;
(2)
plans for significant and continued reinvestment of foreign earnings in organic and inorganic growth initiatives outside the U.S.; and
(3)
remittance restrictions imposed by local governments

GCP will continually analyze and evaluate its cash needs to determine the appropriateness of its indefinite reinvestment assertion.
Refer to Note 4, "Income Taxes," to the Consolidated Financial Statements for additional information.
Financial Condition, Liquidity, and Capital Resources
Following is an analysis of our financial condition, liquidity and capital resources at March 31, 2017 .
Our principal uses of cash generally have been capital investments and acquisitions and working capital investments. In connection with our separation from Grace, we incurred $800.0 million of indebtedness, including $750.0 million borrowed to pay a distribution to Grace prior to the separation and approximately $50 million retained to meet operating requirements and to pay separation associated fees. We believe our liquidity and capital resources, including cash on hand, cash we expect to generate during 2017 and thereafter, future borrowings if any, and other available liquidity and capital resources (discussed further below), are sufficient to finance our operations and growth strategy and to meet our debt obligations.

46


Table of Contents

Divestiture of Darex
In conjunction with the proposed sale of Darex, we expect to receive after-tax net proceeds of approximately $800 million before deal and other one-time costs, subject to customary closing adjustments. We expect to receive these proceeds upon the closing date of the sale, which we anticipate will occur around mid-year 2017. We intend to use these proceeds primarily for general corporate purposes and to repay indebtedness.
Cash Resources and Available Credit Facilities
At March 31, 2017 , we had available liquidity of $372.4 million , consisting of $109.5 million in cash and cash equivalents ($ 26.7 million in the U.S.), $226.0 million available under our revolving credit facility, and $36.9 million of available liquidity under various non-U.S. credit facilities.
Our non-U.S. credit facilities are extended to various subsidiaries that use them primarily to issue bank guarantees supporting trade activity and to provide working capital during occasional cash shortfalls. We generally renew these credit facilities as they expire.
The following table summarizes our non-U.S. credit facilities as of March 31, 2017 :

(In millions)
Maximum Borrowing Amount
 
Available Liquidity
 
Expiration Date
China
$
11.5

 
$
5.7

 
Open end
India
10.0

 
1.9

 
2/3/2021
Singapore
7.6

 
7.6

 
2/3/2021
Australia
6.0

 
3.0

 
2/3/2021
Canada
5.6

 
2.6

 
2/3/2021
Turkey
3.1

 
2.6

 
Open end
United Arab Emirates
2.5

 
2.5

 
11/30/2017
Other countries
11.6

 
11.0

 
Open end
Total
$
57.9

 
$
36.9

 
 



47


Table of Contents

Analysis of Cash Flows
The following table summarizes our cash flows for the first quarter and prior-year quarter :
 
Three Months Ended March 31,
(In millions)
2017
 
2016
Net cash (used in) provided by operating activities from continuing operations
$
(28.0
)
 
$
8.2

Net cash used in investing activities from continuing operations
(9.8
)
 
(12.6
)
Net cash (used in) provided by financing activities from continuing operations
(8.8
)
 
20.6

Net cash used in operating activities from continuing operations for the first quarter was $28.0 million , compared with net cash provided by operating activities of $8.2 million for the prior-year quarter . The year-over-year change was primarily due to a decrease in net income, an increase in inventories, and changes in other assets and liabilities compared with the prior-year quarter. The changes in other assets and liabilities were driven by a $25.4 million increase in cash paid for interest related to our senior notes, as well as other changes in payments for incentive compensation and customer rebates, partially offset by a change in deferred taxes and an increase in accounts payable.
Net cash used in investing activities from continuing operations for the first quarter was $9.8 million , compared with $12.6 million for the prior-year quarter . The year-over-year change was primarily due to cash received in connection with post-closing adjustments related to the Halex acquisition and a decrease in other investing activities compared with the prior-year quarter .
Net cash used in financing activities from continuing operations for the first quarter was $8.8 million , compared with net cash provided by financing activities of $20.6 million in the prior-year quarter . The year-over-year change in cash flow was primarily due to proceeds from the issuance of bonds and indebtedness incurred during the first quarter of 2016 and an increase in repayments under our credit arrangements during the first quarter of 2017.
Included in net cash (used in) provided by operating activities from continuing operations for the three months ended March 31, 2017 and March 31, 2016 , are restructuring payments of $ 0.3 million and $ 1.8 million , respectively, and repositioning payments of $ 1.1 million and $ 3.9 million for the three months ended March 31, 2017 and March 31, 2016 , respectively. These cash flows totaled $1.4 million and $5.7 million for the first quarter and prior-year quarter , respectively.
Debt and Other Contractual Obligations
Total debt outstanding at March 31, 2017 was $820.6 million . Refer to Note 3, "Debt and Other Financial Instruments," to the Consolidated Financial Statements for additional information regarding our debt.
Refer to Note 7, "Commitments and Contingent Liabilities," to the Consolidated Financial Statements for a discussion of financial assurances.
We have various future contractual obligations, including those for debt and related interest payments, pension funding requirements, operating leases and other operating commitments. During the quarter ended March 31, 2017 , there were no material changes to our contractual obligations as previously reported in our Annual Report on Form 10-K for the year ended December 31, 2016 .
Employee Benefit Plans
In the three months ended March 31, 2016, we made an accelerated contribution to the trusts that hold assets of the U.S. qualified pension plans of approximately $1.0 million . We intend to fund non-U.S. pension plans based upon applicable legal requirements as well as actuarial and trustee recommendations. We contributed $0.8 million to these non-U.S. plans during the first quarter of 2017 compared with $0.3 million during the prior-year quarter .
Refer to Note 5, "Pension Plans and Other Postretirement Benefit Plans," to the Consolidated Financial Statements for further discussion.

48


Table of Contents

Other Contingencies
Refer to Note 7, "Commitments and Contingent Liabilities," to the Consolidated Financial Statements for a discussion of other contingencies.
Inflation
We recognize that inflationary pressures may have an adverse effect on us through higher asset replacement costs and higher raw materials and other operating costs. We try to minimize these impacts through effective control of operating expenses and productivity improvements as well as price increases to customers.
We estimate that the cost of replacing our property and equipment today is greater than its historical cost. Accordingly, our depreciation expense would be greater if the expense were stated on a current cost basis.
Venezuela
The operating environment in Venezuela is challenging, with high inflation, governmental restrictions in the form of currency exchange, price and margin controls, importation of raw materials, labor unrest, and the possibility of government actions such as further currency devaluations, business occupations or intervention and expropriation of assets. In addition, the foreign exchange controls in Venezuela limit our ability to purchase raw materials, repatriate earnings, remit dividends and pay intercompany balances at an official exchange rate or at all. Due to our inability to convert local currency at official exchange rates (including the DICOM rate), we have been purchasing imported raw materials from local distributors in local currency with an implicit foreign exchange rate ranging from 2,500 to 4,500 bolivar to one U.S. dollar in the first quarter of 2017.
Effective January 1, 2010, we began to account for Venezuela as a highly inflationary economy. As a result, the functional currency of our Venezuelan subsidiary became the U.S. dollar; therefore, all translation adjustments are reflected in net income in the accompanying Consolidated Statements of Operations.
Effective September 30, 2015, we began accounting for our results in Venezuela at the SIMADI rate. In mid-February 2016, changes to the currency exchange systems were announced that eliminated the SICAD exchange rate and replaced the name SIMADI rate with DICOM. The DICOM rate was 708 bolivars to one U.S. dollar at March 31, 2017, an increase of approximately 4.9% from the rate at December 31, 2016, resulting in an immaterial impact on income from continuing operations.
In March 2017, the Venezuelan government announced that a new exchange rate would be introduced to replace the DICOM rate, although further details have not been publicly announced. We believe the new exchange rate would result in a further devaluation of the local currency and additional currency remeasurement losses in net income.
At March 31, 2017, the monetary net assets denominated in local currency within our Venezuela subsidiary were $8.6 million , of which $5.0 million has been reclassified as "held for sale" on our Consolidated Balance Sheet. Assuming an exchange rate of 3,000 bolivar to one U.S. dollar, the incremental remeasurement loss for the quarter ended March 31, 2017 would have been $6.6 million , of which $2.8 million would have been reported in "Loss from continuing operations before income taxes" and $3.8 million in "Income from discontinued operations, net of income taxes" on our Consolidated Statement of Operations. At March 31, 2017, we also had on our Consolidated Balance Sheet U.S. dollar- and Euro-denominated intercompany payables of approximately $19 million and a negative currency translation adjustment balance of approximately $33 million related to our Venezuela subsidiary.
Critical Accounting Estimates
Refer to the "Critical Accounting Estimates" heading in Item 7 of our Form 10-K for the year ended December 31, 2016 .
Recent Accounting Pronouncements
Refer to Note 1, "Basis of Presentation and Summary of Significant Accounting and Financial Reporting Policies," to the Consolidated Financial Statements for a discussion of recent accounting pronouncements and their potential effect on our results of operations, financial position and related disclosures.

49


Table of Contents

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
With respect to information disclosed in the "Quantitative and Qualitative Disclosures About Market Risk" section of our Annual Report on Form 10-K for the year ended December 31, 2016 (" 2016 Annual Report"), more recent numerical measures and other information are available in the "Financial Statements" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of this Report. These more recent measures and the information disclosed in the "Quantitative and Qualitative Disclosures About Market Risk" section of our 2016 Annual Report are incorporated herein by reference.
Item 4.    CONTROLS AND PROCEDURES
Management’s Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act"), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended March 31, 2017 , that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

50


Table of Contents

PART II. OTHER INFORMATION
Item 1.    LEGAL PROCEEDINGS
Information with respect to this Item may be found in Note 7 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.
Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended December 31, 2016 .
Item 1A.    RISK FACTORS
There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended December 31, 2016 .
Item 6.    EXHIBITS
Exhibit No.
 
Description of Exhibit
10.1*
 
Form of GCP Applied Technologies Inc. Stock Option Award Agreement.***
10.2*
 
Form of GCP Applied Technologies Inc. Restricted Stock Unit Award Agreement.***
10.3*
 
Form of GCP Applied Technologies Inc. Performance-Based Stock Unit Award Agreement.***
31.1*
 
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
 
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32**
 
Certification of the Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
 
XBRL Instance Document
101.SCH*
 
XBRL Taxonomy Extension Schema
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase
* Filed herewith.
** Furnished herewith.
*** Management contract or compensatory plan.

51


Table of Contents

SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
GCP Applied Technologies Inc.
(Registrant)
 
 
 
Date: May 9, 2017
By:
/s/ GREGORY E. POLING
 
 
Gregory E. Poling
President and Chief Executive Officer
(Principal Executive Officer)
 
 
 
Date: May 9, 2017
By:
/s/ DEAN P. FREEMAN
 
 
Dean P. Freeman
Vice President and Chief Financial Officer
(Principal Financial Officer)
 
 
 
Date: May 9, 2017
By:
/s/ KENNETH S. KOROTKIN
 
 
Kenneth S. Korotkin
Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)

52


Table of Contents

EXHIBIT INDEX
Exhibit No.
 
Description of Exhibit
10.1*
 
Form of GCP Applied Technologies Inc. Stock Option Award Agreement.***
10.2*
 
Form of GCP Applied Technologies Inc. Restricted Stock Unit Award Agreement.***
10.3*
 
Form of GCP Applied Technologies Inc. Performance-Based Stock Unit Award Agreement.***
31.1*
 
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
 
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32**
 
Certification of the Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
 
XBRL Instance Document
101.SCH*
 
XBRL Taxonomy Extension Schema
101.CAL*
 
XBRL Taxonomy Extension Calculation Linkbase
101.DEF*
 
XBRL Taxonomy Extension Definition Linkbase
101.LAB*
 
XBRL Taxonomy Extension Label Linkbase
101.PRE*
 
XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.
** Furnished herewith.
*** Management contract or compensatory plan.



53


GCP Applied Technologies Inc.
Equity and Incentive Plan
TERMS AND CONDITIONS
OF
OPTION AWARD
OPTION AWARD granted on February 27, 2017 (the “Grant Date”).
1. Grant of Nonqualified Stock Option. GCP Applied Technologies Inc. has granted to you a Nonqualified Stock Option to purchase _______ Shares, subject to the provisions of these Terms and Conditions and the GCP Applied Technologies Inc. Equity and Incentive Plan, as amended and restated on February 28, 2017 (the “Plan”). Unless defined herein, capitalized terms used in these Terms and Conditions are defined in the Plan.
2. Exercise Price. The Exercise Price required to purchase the Shares subject to this Award is $26.40.
3. Vesting. Except as provided below, Stock Options subject to this Award will vest in substantially equal installments on the first, second and third anniversary of the Grant Date, subject to your continued employment with the Company and/or a Subsidiary through each relevant vesting date. If you experience a Termination of Employment before full (100%) vesting, you will forfeit the unvested portion of this Award immediately upon your Termination of Employment date and you may exercise the then-vested portion of this Award until the earlier of (A) the date described in Section 4 or (B) ninety (90) days after your Termination of Employment date. If, however, you experience a Termination of Employment before full (100%) vesting due to: (i) Retirement (as defined in the Plan, you have attained age 60 and completed at least 5 years of service with the Company and/or a Subsidiary as of your Termination of Employment date) on or after the six (6) month anniversary of the Grant Date; (ii) your death or Disability; or (iii) a Change in Control Termination or a Termination of Employment as a result of a Divestiture or Outsourcing Agreement, Shares subject to this Award will become vested and exercisable in accordance with the provisions of Section 7, 8 or 9, as applicable.
4. Term of Award. Unless this Award has been terminated or cancelled, it will expire on the day before the 10 th anniversary of the Grant Date. If the New York Stock Exchange (“NYSE”) is not open for business on such date, this Award will expire at the close of the NYSE’s first trading day that immediately precedes the day before the 10 th anniversary of the Grant Date. The Stock Options granted by this Award may be exercised at any time before the expiration, termination or cancellation of this Award, provided that the time and manner of exercise is consistent with these Terms and Conditions.

5. Payment of Exercise Price. To exercise all or a portion of this Award, you must pay the Exercise Price for each Share. You may pay the Exercise Price in cash or by certified check, bank draft, wire transfer or postal or express money order or by any other method accepted by the Company, provided that such method of payment is permitted by applicable law at the time of

1 / 1      FY17 Option Award Certificate


exercise. You may pay the Exercise Price by using one or more of the following methods: (A) delivering a properly executed exercise notice to the Company or its agent, together with irrevocable instructions to a broker to deliver promptly to the Company, within the typical settlement cycle for the sale of equity securities on the relevant trading market (or otherwise in accordance with Regulation T issued by the United States Board of Governors of the Federal Reserve System), the amount of sale proceeds with respect to the portion of the Shares to be acquired having a Fair Market Value on the date of exercise equal to the sum of the applicable portion of the Exercise Price being so paid; (B) tendering (actually or by attestation) to the Company or its agent previously acquired Shares that have a Fair Market Value on the day prior to the date of exercise equal to the applicable portion of the Exercise Price being so paid; or (C) instructing the Company to reduce the number of Shares that would otherwise be issued by such number of Shares as have in the aggregate a Fair Market Value on the date of exercise equal to the applicable portion of the Exercise Price being so paid. Notwithstanding the foregoing, you may not tender any form of payment or exercise this Award by any method that the Company determines, in its sole discretion, could violate any applicable law, regulation or Company policy or that is otherwise unacceptable to the Company. You are not required to purchase all Shares subject to this Award at one time, but you must pay the full Exercise Price by a means satisfactory to the Company for all Shares that you elect to purchase before they will be delivered. This Stock Option may not be exercised for fractional Shares. The date of exercise of a Stock Option shall be the date on which the Company receives the Exercise Price for such Stock Option. Notwithstanding anything in this Section 5 to the contrary, if this Award is scheduled to expire due to the expiration of the term on the date described in Section 4 above and the Fair Market Value of a Share on the last day of such term exceeds the Exercise Price for a Share subject to this Award, then, by accepting this Award, you agree that, unless you notify the Company’s third-party administrator (currently E*Trade) at least ten (10) business days before such expiration date that you do not wish for this Award to be exercised, you shall be treated as having instructed the Company to exercise the vested portion of this Award on the last day of such term and to pay the Exercise Price by application of the method described in (C) above or such other method as determined by the Company, provided that such method complies with applicable law.

6. Exercise of Stock Option. If you are entitled to exercise a Stock Option subject to this Award, you may exercise it by contacting E*Trade through its web site at www.etrade.com or by calling 1-800-838-0908. If someone other than you attempts to exercise Stock Options subject to this Award (for example, because the Stock Option is being exercised after your death), the Company will deliver the Shares only after determining that the person attempting to exercise Stock Options subject to this Award is your duly appointed personal representative or an individual to whom this Award has been transferred in accordance with these Terms and Conditions and the terms of the Plan.

7. Retirement, Death or Disability. Notwithstanding the vesting and exercise provisions described in Section 3, if you experience a Termination of Employment due to: (A) your Retirement (as defined in the Plan and described above) on or after the six (6) month anniversary of the Grant Date; or (B) your death or Disability, then you will become fully vested in all Stock Options subject to this Award on the date of such Retirement, your death or your Termination of Employment due to Disability and in any such case be entitled to exercise this Award until the earlier

2/2    FY17 Option Award Certificate


of (i) the date described in Section 4 or (ii) the third anniversary of the date of your Retirement, death or Termination of Employment due to Disability, as applicable.

8. Change in Control. Notwithstanding the vesting and exercise provisions described in Section 3, you will become fully vested in all Stock Options subject to this Award on the date of a Change in Control in the event that a Replacement Award is not issued to you or, on or after a Change in Control, on your Termination of Employment date if you experience a Change in Control Termination and be entitled to exercise this Award until the earlier of (A) the date described in Section 4 or (B) the third anniversary of the Change in Control or your Termination of Employment date, as applicable, if, solely with respect to a Change in Control Termination, you satisfy one of the following requirements:

(i)      On or before the second anniversary of a Change in Control, the Company or any Subsidiary terminates your employment for any reason other than Cause, Disability or death; or

(ii)      On or before the second anniversary of a Change on Control, (A) the Company or any Subsidiary: (1) assigns or causes to be assigned to you, whether formally or informally, duties inconsistent in any material respect with your duties as assigned to you, whether formally or informally, immediately prior to the Change in Control or fails to assign to you, whether formally or informally, immediately after the Change in Control any duties or responsibilities you performed immediately prior to the Change in Control if such duties or responsibilities constitute a material portion of your duties or responsibilities immediately prior to the Change in Control; (2) makes or causes to be made any material adverse change to your position (including a change in title, reporting relationship or level to a title, reporting relationship or level in the organization that is lessor in any respect to your title, reporting relationship or level immediately prior to the Change in Control), authority, duties or responsibilities; or (3) takes or causes to be taken any other action which, in your reasonable judgment, results in a material diminution in your position, authority, duties or responsibilities; or (B) the Company or any Subsidiary, without your consent, (1) requires you to relocate to a principal place of employment more than fifty (50) miles from your existing place of employment and which increases your commute from your principal residence by more than fifty (50) miles; (2) materially reduces your annual base salary; or (3) materially breaches the terms of your compensation package (such as ceasing to provide an annual cash bonus opportunity, a defined benefit retirement plan benefit or an annual long-term share incentive grant) as in effect immediately prior to the Change in Control; provided, however, that (x) within ninety (90) days after an event described in (A) or (B) above, you submit written notice of such event to the Company specifying in reasonable detail the event upon which you are basing your Termination of Employment, (y) the Company has not cured such event within thirty (30) days after its receipt of such notice and (z) within ninety (90) days after the expiration of such cure period, you terminate your employment with the Company.

9. Termination of Employment Resulting From Divestiture or Outsourcing Agreement . Notwithstanding the vesting and exercise provisions described in Section 3, if you

3/3    FY17 Option Award Certificate


experience a Termination of Employment with the Company or a Subsidiary as a result of a Divestiture or Outsourcing Agreement, then Stock Options subject to this Award will vest on a pro-rata basis based on (A) the number of whole months completed from Grant Date through your Termination of Employment date, divided by 36, multiplied by (B) the total number of Stock Options subject to this Award, minus (C) the number of Stock Options subject to this Award that previously vested. If you are entitled to pro-rata vesting under this Section 9, then you will be entitled to exercise the vested portion of this Award until the earlier of (1) the date described in Section 4 or (2) the third anniversary of your Termination of Employment date.

10. Withholdings. The Company has the right, prior to the issuance or delivery of any Shares in connection with the exercise of all or a portion of this Award, to withhold or require from you the amount necessary to satisfy applicable tax requirements ( e.g. , income tax, social insurance, payroll tax and payment on account), as determined by the Company. The methods described in Section 5 may also be used by you to pay, or by the Company to satisfy, your withholding tax obligation, provided that the use of such method for this purpose complies with Company policy and applicable law. If, at any time after the Grant Date, you become subject to tax in more than one jurisdiction, the Company may be required to withhold or account for applicable tax requirements in the various jurisdictions. By accepting this Award, you authorize the Company or any Subsidiary to satisfy applicable tax or tax withholding requirements by: (A) withholding from your wages or other cash compensation payable to you; (B) withholding from any proceeds resulting from the sale of Shares subject to this Award either through an exercise and voluntary sale or through a mandatory sale arranged by the Company on your behalf and pursuant to this authorization; (C) redemption by the Company at Fair Market Value of Shares due to you following the exercise of Shares subject to this Award; or (D) a combination of (A), (B) or (C) above. If the Company or any Subsidiary cannot withhold or account for all taxes associated with this Award by application of the means described herein, then, by accepting this Award, you agree that you will pay to the Company or any Subsidiary all amounts necessary to satisfy applicable tax requirements and acknowledge that the Company may refuse to issue or deliver Shares subject to this Award, or the proceeds from the sale of such Shares, if you do not comply with this obligation.

11. Transfer of Award. You generally may not transfer this Award or any interest herein except by will or the laws of descent and distribution. However, you may transfer this Award to a “family member” (as defined in Section 7.1(b) of the Plan), provided that (A) you do not receive any consideration for the transfer and (B) you furnish the Company’s Vice President, General Counsel and Secretary with written notice of the transfer at least ten (10) business days in advance of such transfer. Notwithstanding the foregoing, any transfer of this Award may be delayed or prohibited if, in the sole discretion of the Company’s Vice President, General Counsel and Secretary, such transfer would violate, or would have the potential to violate, applicable law, regulation or Company policy. If this Award is transferred pursuant to this provision, it will continue to be subject to the same terms and conditions that applied immediately prior to the transfer. This Award may be exercised by the transferee only to the same extent that you could have exercised this Award had no transfer occurred.


4/4    FY17 Option Award Certificate


12. Forfeiture of Award. In addition to the forfeiture provisions that may be applicable to this Award pursuant to Section 7.14 of the Plan, you will forfeit all or a portion of the Shares subject to this Award if your employment terminates under the circumstances described below:

(i)      If the Company or Subsidiary terminates your employment for Cause, including, without limitation, a termination as a result of your violation of the Company’s Code of Conduct, then all unexercised portions of this Award (whether vested or unvested) will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon your Termination of Employment for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all profits you realized upon the exercise of any portion of this Award during the period that begins six (6) months immediately before your Termination of Employment for Cause and ends on the date the Company seeks recoupment pursuant to these Terms and Conditions.

(ii)      If, after your Termination of Employment, the Committee determines in its sole discretion that while you were a Company or Subsidiary employee you engaged in activity that would have constituted grounds for the Company or Subsidiary to terminate your employment for Cause, then all unexercised portions of this Award (whether vested or unvested) will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon the date the Committee determines that you could have been terminated for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all profits you realized upon the exercise of any portion of this Award during the period that begins six (6) months immediately before your Termination of Employment and ends on the date the Company seeks recoupment pursuant to these Terms and Conditions.

(iii)      If the Committee determines in its sole discretion that at any time after your Termination of Employment and prior to the first anniversary of your Termination of Employment you (A) disclosed confidential or proprietary information related to any business of the Company or any Subsidiary or (B) violated the terms of any non-competition agreement by and between you and the Company or any Subsidiary and the Committee has not approved of your employment with a competitor in writing, then all unexercised portions of this Award (whether vested or unvested) will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company, immediately upon the Committee’s determination date, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all profits you realized upon the exercise of any portion of this Award during the period that begins six (6) months immediately before your Termination of Employment and ends on the date of the Company seeks recoupment pursuant to these Terms and Conditions.


5/5    FY17 Option Award Certificate


13. Adjustments. This Award shall be subject to the provisions set forth in Section 5.3 and 5.4(c)(iv) of the Plan, to the extent applicable.

14. Restrictions on Exercise. Exercise of this Award is subject to the conditions that, to the extent required at the time of exercise:

(i)      The Shares covered by this Award will be duly listed, upon official notice of issuance, on the NYSE; and

(ii)      A Registration Statement under the United States Securities Act of 1933 with respect to the Shares will be effective or an exemption from registration will apply.

If there is any registration, qualification, exchange control or other legal requirement imposed upon this Award or the Shares subject to this Award by applicable securities or exchange control laws (including rulings or regulations issued by the United States Securities and Exchange Commission or any other governmental agency with jurisdiction over the issuance of this Award or the Shares subject to this Award), the Company shall not be required to deliver any Shares subject to this Award before the Company, in its sole discretion, has determined that either (A) it has satisfied any such requirements or has received the requisite approval from the appropriate governmental agency; or (B) an exemption from such registration or exchange control requirement applies. By accepting this Award, you acknowledge that you understand that the Company is under no obligation to register this Award or the Shares subject to this Award with any governmental agency or to seek approval from any governmental agency for the issuance or sale of Shares subject to this Award.

15. Disposition of Securities; Acknowledgement of Insider Trading Policy. By accepting this Award, you acknowledge that you have read and understand the Company’s Insider Trading Policy and are aware of and understand your obligations under United States federal securities laws with respect to trading in the Company’s securities. By accepting this Award, you also agree not to use the Company’s “cashless exercise” program (or any successor program) at any time when you possess material non-public information with respect to the Company (including Subsidiaries) or when using the program would otherwise result in a violation of applicable securities law. The Company has the right to recover, or receive reimbursement for, any compensation or profit realized on the exercise of this Award or by the disposition of Shares received upon exercise of this Award to the extent that the Company has a right of recovery or reimbursement under applicable securities laws.
16. Plan Terms Govern. The vesting and exercise of this Award, the disposition of any Shares received upon the exercise of all or a portion of this Award, and the treatment of any gain on the disposition of such Shares are subject to the terms of the Plan and any rules that the Committee prescribes. The Plan document, as amended from time to time, is incorporated into these Terms and Conditions. These Terms and Conditions constitute the Award Certificate referred to in the Plan. If there is any conflict between the terms of the Plan and these Terms and Conditions, the Plan’s terms govern. By accepting this Award, you acknowledge receipt of the Plan and the Plan’s prospectus, as in effect on the Grant Date.

6/6    FY17 Option Award Certificate


17. Personal Data. To comply with applicable law and to administer this Award appropriately, the Company and its agents may accumulate, hold and process your personal data and/or “sensitive personal data” within the meaning of applicable law (“Personal Data”). Personal Data includes, but is not limited to, the information provided to you as part of the grant package and any changes thereto (e.g., details of Stock Options, including amounts awarded, unvested, vested or expired), other appropriate personal and financial data about you (e.g., name, home address, telephone number, date of birth, nationality, job title, reason for termination of employment, and social security, social insurance or other identification number), and information about your participation in the Plan and Shares obtained under the Plan from time to time. By accepting this Award, you give your explicit consent to your employer’s and the Company’s accumulating, transferring, and processing Personal Data as necessary or appropriate for Plan administration. Your Personal Data will be retained only as long as is necessary to administer your participation in the Plan. If applicable, by accepting this Award, you also give your explicit consent to the Company’s transfer of Personal Data outside the country in which you work or reside and to the United States of America where the same level of data protection laws may not apply as in your home country. The legal persons for whom your Personal Data are intended (and by whom your Personal Data may be transferred, processed or exchanged) include the Company, its Subsidiaries (or former Subsidiaries as are deemed necessary), the outside Plan administrator, their respective agents, and any other person that the Company retains or utilizes for compensation planning or Plan administration purposes. You have the right to request a list of the names and addresses of any potential recipients of your Personal Data and to review and correct your Personal Data by contacting your local Human Resources Representative. By accepting this Award, you acknowledge your understanding that the transfer of the information outlined here is important to Plan administration and that failure to consent to the transmission of such information may limit or prohibit your participation in the Plan. By accepting this Award, you acknowledge that you are providing the consents herein on a purely voluntary basis and that, if you do not consent or if you later seek to revoke your consent, it will adversely impact the ability of the Company to administer your Awards but it will not adversely impact your employment status or service with your employer.
18. No Contract of Employment or Promise of Future Grants. By accepting this Award, you agree that you are bound by the terms of the Plan and these Terms and Conditions and acknowledge that this Award is granted in the Company’s sole discretion and is not considered part of any employment contract or your ordinary or expected salary or other compensation for services of any kind rendered to the Company or any Subsidiary. You further agree that this Award, and your Plan participation, do not form, and will not be interpreted as forming, an employment contract or guarantee of employment with the Company or any Subsidiary. The Company, in its sole discretion, voluntarily established the Plan and may amend or terminate it at any time pursuant to the terms of the Plan. You understand that the grant of Stock Options under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants of any Stock Options, or benefits in lieu of any Stock Options, even if Stock Options have been granted repeatedly in the past, and that all decisions with respect to future grants will be in the Company’s sole discretion. By accepting this Award, you also acknowledge that this Award and any gains received hereunder are extraordinary items and are not considered part of your salary or compensation for purposes of any pension or retirement benefits or for purposes of calculating any termination, severance, redundancy, resignation, end of service payments, bonuses, long-service

7/7    FY17 Option Award Certificate


awards, life or accident insurance benefits or similar payments. Neither this Award, nor any gains received hereunder, is intended to replace any pension rights or compensation. If the Company or Subsidiary terminates your employment for any reason, you agree that you will not be entitled to damages or compensation for breach of contract, dismissal (in any circumstances, including unfair dismissal) or compensation for any loss of office or otherwise to any sum, Shares, Stock Options or other benefits to compensate you for the loss or diminution in value of any actual or prospective rights, benefits or expectation under or in relation to the Plan.
19. Limitations. Nothing in these Terms and Conditions or the Plan grants to you any right to continued employment with the Company or any Subsidiary or to interfere in any way with the Company or Subsidiary’s right to terminate your employment at any time and for any reason, subject to applicable law. Payment of Shares is not secured by a trust, insurance contract or other funding medium, and you do not have any interest in any fund or specific Company or Subsidiary asset by reason of this Award. You have no rights as a stockholder of the Company pursuant to this Award until Shares are actually delivered to you.
20. Entire Agreement and Amendment. These Terms and Conditions and the Plan constitute the entire understanding between you and the Company regarding this Award. These Terms and Conditions supersede any prior agreements, commitments or negotiations concerning this Award. These Terms and Conditions may not be modified, altered or changed except by the Committee (or its delegate) in writing and pursuant to the terms of the Plan; provided, however, that the Company has the unilateral authority to amend these Terms and Conditions without your consent to the extent necessary to comply with applicable securities registration or exchange control requirements and to impose additional requirements on this Award or Shares subject to this Award if the Company, in its sole discretion, deems it necessary or advisable for legal or administrative reasons.
21. Severability. The invalidity or unenforceability of any provision of these Terms and Conditions will not affect the validity or enforceability of the other provisions of these Terms and Conditions, which will remain in full force and effect. Moreover, if any provision is found to be excessively broad in duration, scope or covered activity, the provision will be construed so as to be enforceable to the maximum extent compatible with applicable law.
22. Waiver. By accepting this Award, you acknowledge that a waiver by the Company of any breach by you of a provision of these Terms and Conditions shall not operate or be construed as a waiver by the Company of any other provision of these Terms and Conditions or of a subsequent breach.
23. Notices. By accepting this Award, you agree to receive documents, notices and any other communications relating to your participation in the Plan in writing by regular mail to your last known address on file with your employer, the Company or Subsidiary or any outside Plan administrator, or by electronic means, including by e-mail, through an online system maintained by any outside Plan administrator, or by a posting on the Company’s intranet website or on an online system or website maintained by any outside Plan administrator.

8/8    FY17 Option Award Certificate


24. Governing Law. This Award and these Terms and Conditions are governed by the law of the State of Delaware and shall be construed accordingly.
25. Code Section 409A Compliance. Notwithstanding any other provision of these Terms and Conditions to the contrary, in the event that all or a portion of this Award becomes subject to Code Section 409A, the provisions contained in Section 7.11 of the Plan (entitled “ Section 409A Compliance ”) shall govern and shall supersede any applicable provision of these Terms and Conditions.
26. Acceptance. By accepting this Award, you agree to the following:
(i)      You have carefully read, fully understand and agree to all of the terms and conditions contained in the Plan and these Terms and Conditions; and
(ii)      You understand and agree that the Plan and these Terms and Conditions constitute the entire understanding between you and the Company regarding this Award, and that any prior agreements, commitments or negotiations concerning this Award are replaced and superseded.

9/9    FY17 Option Award Certificate

GCP Applied Technologies Inc.
Equity and Incentive Plan
TERMS AND CONDITIONS
OF
RESTRICTED STOCK UNIT AWARD
RESTRICTED STOCK UNIT AWARD granted on February 27, 2017 (the “Grant Date”).
1. Grant of Restricted Stock Units. GCP Applied Technologies Inc. has granted to you _______ Restricted Stock Units, subject to the provisions of these Terms and Conditions and the GCP Applied Technologies Inc. Equity and Incentive Plan, as amended and restated on February 28, 2017 (the “Plan”). The Company will hold the Restricted Stock Units in a bookkeeping account on your behalf until such units become payable or are forfeited or cancelled. Unless defined herein, capitalized terms used in these Terms and Conditions are defined in the Plan.
2. Amount and Form of Payment. Each Restricted Stock Unit represents one (1) Share and vested Restricted Stock Units will be redeemed solely for Shares, subject to Section 9.
3. Vesting. Except as provided below, Restricted Stock Units subject to this Award will vest in substantially equal installments and be immediately settled on the first, second and third anniversary of the Grant Date, subject to your continued employment with the Company and/or a Subsidiary through each relevant vesting date. If you experience a Termination of Employment before full (100%) vesting, you will forfeit the unvested portion of Restricted Stock Units. If, however, you experience a Termination of Employment due to: (A) Retirement (as defined in the Plan, you attained age 60 and complete at least 5 years of service with the Company and/or a Subsidiary as of your Termination of Employment date) on or after the six (6) month anniversary of the Grant Date; (B) your death or Disability; or (C) a Change in Control Termination or Termination of Employment as a result of a Divestiture or Outsourcing Agreement, Restricted Stock Units subject to this Award will become vested in accordance with the provisions of Section 4, 5 or 6, as applicable.
4. Retirement, Death or Disability. Notwithstanding the vesting provisions described in Section 3, if you experience a Termination of Employment: (A) as a result of your Retirement (as defined in the Plan and described above) on or after the six (6) month anniversary of the Grant Date; or (B) due to your death or Disability, then you will become fully vested in all Restricted Stock Units subject to this Award on the date of such Retirement or your death or Termination of Employment due to Disability and at such time all such Awards will be immediately settled.
 
5. Change in Control. Notwithstanding the vesting provisions described in Section 3, you will become fully vested in all Restricted Stock Units subject to this Award on the date of a Change in Control in the event that a Replacement Award is not issued to you or, on or after a Change in Control, on your Termination of Employment date if you experience a Change in Control Termination if, solely with respect to a Change in Control Termination, you satisfy one of the following requirements:

(i)      On or before the second anniversary of a Change in Control, the Company or any Subsidiary terminates your employment for any reason other than Cause, Disability or death; or

(ii)      On or before the second anniversary of a Change on Control, (A) the Company or any Subsidiary (1) assigns or causes to be assigned to you, whether formally or informally, duties inconsistent in any material respect with your duties as assigned to you, whether formally or informally, immediately prior to the Change in Control or fails to assign to you, whether formally or informally, immediately after the Change in Control any duties or responsibilities you performed immediately prior to the Change in Control if such duties or responsibilities constitute a material portion of your duties or responsibilities immediately prior to the Change in Control; (2) makes or causes to be made any material adverse change to your position (including a change in title, reporting relationship or level to a title, reporting relationship or level in the organization that is lessor in any respect to your title, reporting relationship or level immediately prior to the Change in Control), authority, duties or responsibilities; or (3) takes or causes to be taken any other action which, in your reasonable judgment, results in a material diminution in your position, authority, duties or responsibilities; or (B) the Company or any Subsidiary, without your consent, (1) requires you to relocate to a principal place of employment more than fifty (50) miles from your existing place of employment and which increases your commute from your principal residence by more than fifty (50) miles; (2) materially reduces your base salary; or (3) materially breaches the terms of your compensation package (such as ceasing to provide an annual cash bonus opportunity, a defined benefit retirement plan benefit or an annual long-term share incentive grant) as in effect immediately prior to the Change in Control; provided, however, that (x) within ninety (90) days after an event described in (A) or (B) above you submit written notice of such event to the Company specifying in reasonable detail the event upon which you are basing your termination, (y) the Company has not cured such event within thirty (30) days after its receipt of such notice and (z) within ninety (90) days after the expiration of such cure period, you terminate your employment with the Company.

6. Termination of Employment Resulting From Divestiture or Outsourcing Agreement . Notwithstanding the vesting provisions described in Section 3, if you experience a Termination of Employment with the Company or a Subsidiary as a result of a Divestiture or Outsourcing Agreement, then Restricted Stock Units subject to this Award will vest on a pro-rata basis based on (A) the number of whole months completed from Grant Date through your Termination of Employment date, divided by 36, multiplied by (B) the total number of Restricted Stock Units subject to this Award, minus (C) the number of Restricted Stock Units subject to this Award that previously vested.

7. Withholdings. The Company has the right, prior to the issuance or delivery of any Shares subject to this Award, to withhold or require from you the amount necessary to satisfy applicable tax requirements (e.g., income tax, social insurance, payroll tax and payment on account), as determined by the Company. If, at any time after the Grant Date, you become subject to tax in more than one jurisdiction, the Company may be required to withhold or account for applicable tax requirements in the various jurisdictions. By accepting this Award, you authorize the Company or any Subsidiary to satisfy applicable tax or tax withholding requirements by: (A) withholding from your wages or other cash compensation payable to you; (B) withholding from any proceeds resulting from the sale of Shares subject to this Award either through a voluntary sale or through a mandatory sale arranged by the Company on your behalf and pursuant to this authorization; (C) redemption by the Company at Fair Market Value of Shares due to you following the vesting of Shares subject to this Award; or (D) a combination of (A), (B) or (C) above. If the Company or any Subsidiary cannot withhold or account for all taxes associated with this Award, by application of the means described herein, then, by accepting this Award, you agree that you will pay to the Company or any Subsidiary all amounts necessary to satisfy applicable tax requirements and acknowledge that the Company may refuse to issue or deliver Shares subject to this Award, or the proceeds from the sale of such Shares, if you do not comply with such obligations.

8. Transfer of Award. You may not transfer this Award or any interest in Restricted Stock Units except by will or the laws of descent and distribution. Any other attempt to transfer this Award or any interest in Restricted Stock Units is null and void.

9. Forfeiture of Award. In addition to the forfeiture provisions that may be applicable to this Award under Section 7.14 of the Plan, you will forfeit all or a portion of the Restricted Stock Units subject to this Award if your employment terminates under the circumstances described below:

(i)      If the Company or Subsidiary terminates your employment for Cause, including, without limitation, a termination as a result of your violation of the Company’s Code of Conduct, then all unvested Restricted Stock Units subject to this Award will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon your Termination of Employment for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all Restricted Stock Units subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment for Cause and ends on the date the Company seeks recoupment pursuant to these Terms and Conditions.

(ii)      If, after your Termination of Employment, the Committee determines in its sole discretion that while you were a Company or Subsidiary employee you engaged in activity that would have constituted grounds for the Company or Subsidiary to terminate your employment for Cause, then all unvested Restricted Stock Units subject to this Award will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon the date the Committee determines that you could have been terminated for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all Restricted Stock Units subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment and ends on the date that the Committee determines that you could have been terminated for Cause.

(iii)      If the Committee determines in its sole discretion that at any time after your Termination of Employment and prior to the first anniversary of your Termination of Employment you (A) disclosed confidential or proprietary information related to any business of the Company or any Subsidiary or (B) violated the terms of any non-competition agreement by and between you and the Company or any Subsidiary and the Committee has not approved of your employment with a competitor in writing, then all unvested Restricted Stock Units subject to this Award will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company, immediately upon the Committee’s determination date, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all Restricted Stock Units subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment and ends on the date of the Committee’s determination.

10. Adjustments. This Award shall be subject to the provisions set forth in Sections 5.3 and 5.4(c)(iv) of the Plan, to the extent applicable.

11. Restrictions on Payment of Shares. Payment of Shares for Restricted Stock Units is subject to the conditions that, to the extent required at the time of delivery of such Shares:

(i)      The Shares covered by this Award will be duly listed, upon official notice of issuance, on the NYSE; and

(ii)      A Registration Statement under the United States Securities Act of 1933 with respect to the Shares will be effective or an exemption from registration will apply.

If there is any registration, qualification, exchange control or other legal requirement imposed upon this Award or the Shares subject to this Award by applicable securities or exchange control laws (including rulings or regulations issued by the United States Securities and Exchange Commission or any other governmental agency with jurisdiction over the issuance of this Award or the Shares subject to this Award), the Company shall not be required to deliver any Shares subject to this Award before the Company, in its sole discretion, has determined that either (a) it has satisfied any such requirements or has received the requisite approval from the appropriate governmental agency; or (b) an exemption from such registration or exchange control requirement applies. By accepting this Award, you acknowledge that you understand that the Company is under no obligation to register this Award or the Shares subject to this Award with any governmental agency or to seek approval from any governmental agency for the issuance or sale of Shares subject to this Award.

12. Disposition of Securities; Acknowledgement of Insider Trading Policy. By accepting this Award, you acknowledge that you have read and understand the Company’s Insider Trading Policy and are aware of and understand your obligations under United States federal securities laws with respect to trading in the Company’s securities. By accepting this Award, you acknowledge that you understand that your country of residence may impose insider trading and/or market abuse restrictions which may affect your ability to acquire or sell Shares subject to this Award, that such restrictions are separate from and in addition to any restrictions that may be imposed by the Company, that it is your responsibility to comply with such restrictions and that you have been advised to consult with your personal advisor with respect to such restrictions. The Company has the right to recover, or receive reimbursement for, any compensation or profit realized on the disposition of Shares received for Restricted Units to the extent that the Company has a right of recovery or reimbursement under applicable securities laws.

13. Plan Terms Govern. The vesting of Restricted Stock Units, the disposition of any Shares received on or after such vesting, and the treatment of any gains received upon such disposition are subject to the terms of the Plan and any rules that the Committee prescribes. The Plan document, as amended from time to time, is incorporated into these Terms and Conditions. These Terms and Conditions constitute the Award Certificate referred to in the Plan. If there is any conflict between the terms of the Plan and these Terms and Conditions, the Plan’s terms govern. By accepting this Award, you acknowledge receipt of the Plan and the Plan prospectus, as in effect on the Grant Date.

14. Personal Data. To comply with applicable law and to administer this Award appropriately, the Company and its agents may accumulate, hold and process your personal data and/or “sensitive personal data” within the meaning of applicable law (“Personal Data”). Personal Data includes, but is not limited to, the information provided to you as part of the grant package and any changes thereto (e.g., details of Restricted Stock Units, including amounts awarded, unvested, or vested), other appropriate personal and financial data about you (e.g., name, home address, telephone number, date of birth, nationality, job title, reason for termination of employment and social security, social insurance or other identification number), and information about your participation in the Plan and Shares obtained under the Plan from time to time. By accepting this Award, you give your explicit consent to your employer’s and the Company’s accumulating, transferring, and processing Personal Data as necessary or appropriate for Plan administration. Your Personal Data will be retained only as long as is necessary to administer your participation in the Plan. If applicable, by accepting this Award, you also give your explicit consent to the Company’s transfer of Personal Data outside the country in which you work or reside and to the United States of America where the same level of data protection laws may not apply as in your home country. The legal persons for whom your Personal Data are intended (and by whom your Personal Data may be transferred, processed or exchanged) include the Company, its Subsidiaries (or former Subsidiaries as are deemed necessary), the outside Plan administrator, their respective agents, and any other person that the Company retains or utilizes for compensation planning or Plan administration purposes. You have the right to request a list of the names and addresses of any potential recipients of your Personal Data and to review and correct your Personal Data by contacting your local Human Resources Representative. By accepting this Award, you acknowledge your understanding that the transfer of the information outlined here is important to Plan administration and that failure to consent to the transmission of such information may limit or prohibit your participation in the Plan. By accepting this Award, you acknowledge that you are providing the consents herein on a purely voluntary basis and that, if you do not consent or if you later seek to revoke your consent, it will impact the ability of the Company to administer your Awards but it will not adversely impact your employment status or service with your employer.

15. No Contract of Employment or Promise of Future Grants. By accepting this Award, you agree that you are bound by the terms of the Plan and these Terms and Conditions and acknowledge that this Award is granted in the Company’s sole discretion and is not considered part of any employment contract or your ordinary or expected salary or other compensation for services of any kind rendered to the Company or any Subsidiary. You further agree that this Award, and your Plan participation, do not form, and will not be interpreted as forming, an employment contract or guarantee of employment with the Company or any Subsidiary. The Company, in its sole discretion, voluntarily established the Plan and may amend or terminate it at any time pursuant to the terms of the Plan. You understand that the grant of restricted units under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants of any restricted units, or benefits in lieu of restricted units, even if restricted units have been granted repeatedly in the past and that all decisions with respect to future grants will be in the Company’s sole discretion. By accepting this Award, you also acknowledge that this Award and any gains received hereunder are extraordinary items and are not considered part of your salary or compensation for purposes of any pension or retirement benefits or for purposes of calculating any termination, severance, redundancy, resignation, end of service payments, bonuses, long-service awards, life or accident insurance benefits or similar payments. Neither this Award, nor any gains received hereunder, is intended to replace any pension rights or compensation. If the Company or Subsidiary terminates your employment for any reason, you agree that you will not be entitled to damages or compensation for breach of contract, dismissal (in any circumstances, including unfair dismissal) or compensation for any loss of office or otherwise to any sum, Shares, Restricted Units or other benefits to compensate you for the loss or diminution in value of any actual or prospective rights, benefits or expectation under or in relation to the Plan.
16. Limitations. Nothing in these Terms and Conditions or the Plan grants to you any right to continued employment with the Company or any Subsidiary or to interfere in any way with the Company or Subsidiary’s right to terminate your employment at any time and for any reason, subject to applicable law. Payment of Shares is not secured by a trust, insurance contract or other funding medium, and you do not have any interest in any fund or specific Company or Subsidiary asset by reason of this Award. You have no rights as a stockholder of the Company pursuant to this Award until Shares are actually delivered to you.
17. Entire Agreement and Amendment. These Terms and Conditions, the Grant Letter, and the Plan constitute the entire understanding between you and the Company regarding this Award. These Terms and Conditions supersede any prior agreements, commitments or negotiations concerning this Award. These Terms and Conditions may not be modified, altered or changed except by the Committee (or its delegate) in writing and pursuant to the terms of the Plan; provided, however, that the Company has the unilateral authority to amend these Terms and Conditions without your consent to the extent necessary to comply with applicable securities registration or exchange control requirements and to impose additional requirements on this Award or Shares subject to this Award if the Company, in its sole discretion, deems it necessary or advisable for legal or administrative reasons.
18. Severability. The invalidity or unenforceability of any provision of these Terms and Conditions will not affect the validity or enforceability of the other provisions of these Terms and Conditions, which will remain in full force and effect. Moreover, if any provision is found to be excessively broad in duration, scope or covered activity, the provision will be construed so as to be enforceable to the maximum extent compatible with applicable law.
19. Waiver. By accepting this Award, you acknowledge that a waiver by the Company of any breach by you of a provision of these Terms and Conditions shall not operate or be construed as a waiver by the Company of any other provision of these Terms and Conditions or of a subsequent breach.
20. Notices . By accepting this Award, you agree to receive documents, notices and any other communications relating to your participation in the Plan in writing by regular mail to your last known address on file with your employer, the Company or Subsidiary or any outside Plan administrator, or by electronic means, including by e-mail, through an online system maintained by any outside Plan administrator, or by a posting on the Company’s intranet website or on an online system or website maintained by any outside Plan administrator.
21. Governing Law. This Award and these Terms and Conditions are governed by the law of the State of Delaware and shall be construed accordingly.
22. Code Section 409A Compliance. Notwithstanding any other provision of these Terms and Conditions to the contrary, in the event that all or a portion of this Award becomes subject to Code Section 409A, the provisions contained in the section of the Plan entitled “ Section 409A Compliance ” shall govern and shall supersede any applicable provision of these Terms and Conditions.
23. Acceptance . By accepting this Award, you agree to the following:
(i)      You have carefully read, fully understand and agree to all of the terms and conditions contained in the Plan and these Terms and Conditions; and
(ii)      You understand and agree that the Plan and these Terms and Conditions constitute the entire understanding between you and the Company regarding this Award, and that any prior agreements, commitments or negotiations concerning this Award are replaced and superseded.

1 / 1      FY17 RSU Award Certificate

GCP Applied Technologies Inc.
Equity and Incentive Plan
TERMS AND CONDITIONS
OF
PERFORMANCE-BASED STOCK UNIT AWARD FY17-FY19 PERFORMANCE PERIOD
PERFORMANCE-BASED STOCK UNIT AWARD granted on February 27, 2017 (the “Grant Date”).
1. Grant of Performance-Based Stock Units. GCP Applied Technologies Inc. has granted to you _______ Performance-Based Stock Units (“PBUs”), subject to the provisions of these Terms and Conditions and the GCP Applied Technologies, Inc. Equity and Incentive Plan, as amended and restated on February 28, 2017 (the “Plan”). The Company will hold the PBUs in a bookkeeping account on your behalf until such units become payable or are forfeited or cancelled. Unless defined herein (including in the Appendix), capitalized terms used in these Terms and Conditions are defined in the Plan.
2. Amount and Form of Payment. Each PBU represents one (1) Share and vested PBUs will be redeemed solely for Shares, subject to Section 9.
3. Vesting.
(i)      Except as provided below, PBUs subject to this Award will fully vest and be immediately settled on the Committee Certification Date (as defined in Appendix A), provided that you are an Employee on the Committee Certification Date. The target number of PBUs subject to this Award shall be adjusted at the end of the Performance Period based on the attained level of achievement for the Performance Period (as described in Appendix A).
(ii)      If you experience a Termination of Employment before the Committee Certification Date, you will forfeit the unvested portion of PBUs. If, however, you experience a Termination of Employment before the Committee Certification Date due to: (A) Retirement (as defined in the Plan, you attained age 60 and completed at least 5 years of service as of your Termination of Employment date) on or after the six (6) month anniversary of the Grant Date; (B) your death or Disability; or (C) a Change in Control Termination or Termination of Employment as a result of a Divestiture or Outsourcing Agreement, PBUs subject to this Award will become vested in accordance with the provisions of Section 4, 5 or 6, as applicable.
4. Retirement, Death or Disability. Notwithstanding the vesting provisions described in Section 3, if you experience a Termination of Employment as a result of your Retirement (as defined in the Plan and described above) on or after the six (6) month anniversary of the Grant Date or due to your death or Disability, and had you continued in employment through the Committee Certification Date you would have become fully vested in the PBUs subject to this Award, then you will become fully vested in the total number of PBUs subject to this Award that would have become fully vested after adjustment for the attained level of achievement. If you are entitled to full vesting of PBUs pursuant to this Section 4, such vesting shall occur at the same time and in the same manner as the vesting of active employees in PBUs attributable to the Performance Period (i.e., upon the Committee Certification Date) and shall, in no event, become vested or delivered prior to such time.
 
5. Change in Control. Notwithstanding the vesting provisions described in Section 3, in the event of a Change in Control, you will become vested in PBUs subject to this Award in the following manner and under the following circumstances:

(i)      If a Replacement Award is not issued to you upon the Change in Control, then you shall be entitled to pro rata vesting of PBUs subject to this Award based on (A) the number of whole months you completed from the first day of the Performance Period through the Change in Control date, divided by 36, multiplied by (B) the number of PBUs determined by adjusting the total number of PBUs subject to this Award for the attained level of achievement determined in the sole discretion of the Committee as constituted immediately prior to the Change in Control and based on the performance period that begins on the first day of the Performance Period and that ends on the Change in Control date. If you are entitled to pro rata vesting of any PBUs pursuant to this Section 5(i), such vesting shall occur on the date the Committee certifies the attained level of performance, but in no event shall such vesting occur later than thirty (30) calendar days after the Change in Control date.

(ii)      If a Replacement Award is issued to you upon a Change in Control and you experience a Termination of Employment as a result of a Change in Control Termination, then you shall be entitled to pro rata vesting of PBUs subject to this Award based on (A) the number of whole months you completed from the first day of the Performance Period through your Change in Control Termination date, divided by 36, multiplied by (B) the total number of PBUs subject to this Award that would have become vested had you continued in employment through the Committee Certification Date (i.e., after adjustment for the attained level of achievement). If you are entitled to pro rata vesting of any PBUs pursuant to this Section 5(ii), such vesting shall occur at the same time and in the same manner as the vesting of active employees in performance-based stock unit awards attributable to the Performance Period (i.e., upon the Committee Certification Date) and shall, in no event, become vested or delivered prior to such time. Notwithstanding the foregoing, if, upon a Change in Control, the vesting of PBUs subject to this Award ceases to be subject to the satisfaction of performance criteria and instead this Award vests solely based on the continuation of your employment and you experience a Termination of Employment as a result of a Change in Control Termination, then you shall be entitled to pro rata vesting of PBUs subject to this Award based on the amount determined pursuant to (A) above multiplied by the total number of PBUs subject to this Award (after adjustment, if any, when this Award was converted to a solely time-based vested award) and such vesting shall occur as of your Termination of Employment date.

6. Termination of Employment Resulting From Divestiture or Outsourcing Agreement . Notwithstanding the vesting provisions described in Section 3, if you experience a Termination of Employment as a result of a Divestiture or Outsourcing Agreement, then you shall be entitled to pro rata vesting of PBUs subject to this Award based on (A) the number of whole months you completed from the first day of the Performance Period through your Termination of Employment date, divided by 36, multiplied by (B) the total number of PBUs subject to this Award that would have become vested had you continued in employment through the Committee Certification Date (i.e., after adjustment for the attained level of achievement). If you are entitled to pro rata vesting of any PBUs pursuant to this Section 6, such vesting shall occur at the same time and in the same manner as the vesting of active employees in performance-based stock unit awards attributable to the Performance Period (i.e., upon the Committee Certification Date) and shall, in no event, become vested or delivered prior to such time.
  
7. Withholdings. The Company has the right, prior to the issuance or delivery of any Shares subject to this Award, to withhold or require from you the amount necessary to satisfy applicable tax requirements (e.g., income tax, social insurance, payroll tax and payment on account), as determined by the Company. If, at any time after the Grant Date, you become subject to tax in more than one jurisdiction, the Company may be required to withhold or account for applicable tax requirements in the various jurisdictions. By accepting this Award, you authorize the Company or any Subsidiary to satisfy applicable tax or tax withholding requirements by: (i) withholding from your wages or other cash compensation payable to you; (ii) withholding from any proceeds resulting from the sale of Shares subject to this Award either through a voluntary sale or through a mandatory sale arranged by the Company on your behalf and pursuant to this authorization; (iii) redemption by the Company at Fair Market Value of Shares due to you following the vesting of Shares subject to this Award; or (iv) a combination of (i), (ii) or (iii) above. If the Company or any Subsidiary cannot withhold or account for all taxes associated with this Award, by application of the means described herein, then, by accepting this Award, you agree that you will pay to the Company or any Subsidiary all amounts necessary to satisfy applicable tax requirements and acknowledge that the Company may refuse to issue or deliver Shares subject to this Award, or the proceeds from the sale of such Shares, if you do not comply with such obligations.

8. Transfer of Award. You may not transfer this Award or any interest in PBUs except by will or the laws of descent and distribution. Any other attempt to transfer this Award or any interest in PBUs is null and void.

9. Forfeiture of Award. In addition to the forfeiture provisions that may be applicable to this Award under Section 7.14 of the Plan, you will forfeit all or a portion of the PBUs subject to this Award if your employment terminates under the circumstances described below:

(i)      If the Company or Subsidiary terminates your employment for Cause, including, without limitation, a termination as a result of your violation of the Company’s Code of Conduct, then all unvested PBUs subject to this Award will immediately and automatically terminate and you will forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon your Termination of Employment for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all PBUs subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment for Cause and ends on the date the Company seeks recoupment pursuant to these Terms and Conditions.

(ii)      If, after your Termination of Employment, the Committee determines in its sole discretion that while you were a Company or Subsidiary employee you engaged in activity that would have constituted grounds for the Company or Subsidiary to terminate your employment for Cause, then all unvested PBUs subject to this Award will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company immediately upon the date the Committee determines that you could have been terminated for Cause, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all PBUs subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment and ends on the date that the Committee determines that you could have been terminated for Cause.

(iii)      If the Committee determines in its sole discretion that at any time after your Termination of Employment and prior to the first anniversary of your Termination of Employment you (A) disclosed confidential or proprietary information related to any business of the Company or any Subsidiary or (B) violated the terms of any non-competition agreement by and between you and the Company or any Subsidiary and the Committee has not approved of your employment with a competitor in writing, then all unvested PBUs subject to this Award will immediately and automatically terminate and you will immediately and automatically forfeit all rights you have with respect to this Award. Also, by accepting this Award, you agree and promise to deliver to the Company, immediately upon the Committee’s determination date, Shares (or, in the discretion of the Company, cash) equal in value to the amount of all PBUs subject to this Award that vested during the period that begins six (6) months immediately before your Termination of Employment and ends on the date of the Committee’s determination.

10. Adjustments. This Award shall be subject to the provisions set forth in Sections 5.3 and 5.4(c)(iv) of the Plan, to the extent applicable.

11. Restrictions on Payment of Shares. Payment of Shares for PBUs is subject to the conditions that, to the extent required at the time of delivery of such Shares:

(i)      The Shares covered by this Award will be duly listed, upon official notice of issuance, on the NYSE; and

(ii)      A Registration Statement under the United States Securities Act of 1933 with respect to the Shares will be effective or an exemption from registration will apply.

If there is any registration, qualification, exchange control or other legal requirement imposed upon this Award or the Shares subject to this Award by applicable securities or exchange control laws (including rulings or regulations issued by the United States Securities and Exchange Commission or any other governmental agency with jurisdiction over the issuance of this Award or the Shares subject to this Award), the Company shall not be required to deliver any Shares subject to this Award before the Company, in its sole discretion, has determined that either (a) it has satisfied any such requirements or has received the requisite approval from the appropriate governmental agency; or (b) an exemption from such registration or exchange control requirement applies. By accepting this Award, you acknowledge that you understand that the Company is under no obligation to register this Award or the Shares subject to this Award with any governmental agency or to seek approval from any governmental agency for the issuance or sale of Shares subject to this Award.

12. Disposition of Securities; Acknowledgement of Insider Trading Policy. By accepting this Award, you acknowledge that you have read and understand the Company’s Insider Trading Policy and are aware of and understand your obligations under United States federal securities laws with respect to trading in the Company’s securities. By accepting this Award, you acknowledge that you understand that your country of residence may impose insider trading and/or market abuse restrictions which may affect your ability to acquire or sell Shares subject to this Award, that such restrictions are separate from and in addition to any restrictions that may be imposed by the Company, that it is your responsibility to comply with such restrictions and that you have been advised to consult with your personal advisor with respect to such restrictions. The Company has the right to recover, or receive reimbursement for, any compensation or profit realized on the disposition of Shares received for PBUs to the extent that the Company has a right of recovery or reimbursement under applicable securities laws.

13. Plan Terms Govern. The vesting of PBUs, the disposition of any Shares received on or after such vesting, and the treatment of any gains received upon such disposition are subject to the terms of the Plan and any rules that the Committee prescribes. The Plan document, as amended from time to time, is incorporated into these Terms and Conditions. These Terms and Conditions, including the Appendix, constitute the Award Certificate referred to in the Plan. If there is any conflict between the terms of the Plan and these Terms and Conditions, the Plan’s terms govern. By accepting this Award, you acknowledge receipt of the Plan and the prospectus, as in effect on the Grant Date.

14. Personal Data. To comply with applicable law and to administer this Award appropriately, the Company and its agents may accumulate, hold and process your personal data and/or “sensitive personal data” within the meaning of applicable law (“Personal Data”). Personal Data includes, but is not limited to, the information provided to you as part of the grant package and any changes thereto (e.g., details of PBUs, including amounts awarded, unvested, or vested), other appropriate personal and financial data about you (e.g., name, home address, telephone number, date of birth, nationality, job title, reason for termination of employment and social security, social insurance or other identification number), and information about your participation in the Plan and Shares obtained under the Plan from time to time. By accepting this Award, you give your explicit consent to your employer’s and the Company’s accumulating, transferring, and processing Personal Data as necessary or appropriate for Plan administration. Your Personal Data will be retained only as long as is necessary to administer your participation in the Plan. If applicable, by accepting this Award, you also give your explicit consent to the Company’s transfer of Personal Data outside the country in which you work or reside and to the United States of America where the same level of data protection laws may not apply as in your home country. The legal persons for whom your Personal Data are intended (and by whom your Personal Data may be transferred, processed or exchanged) include the Company, its Subsidiaries (or former Subsidiaries as are deemed necessary), the outside Plan administrator, their respective agents, and any other person that the Company retains or utilizes for compensation planning or Plan administration purposes. You have the right to request a list of the names and addresses of any potential recipients of your Personal Data and to review and correct your Personal Data by contacting your local Human Resources Representative. By accepting this Award, you acknowledge your understanding that the transfer of the information outlined here is important to Plan administration and that failure to consent to the transmission of such information may limit or prohibit your participation in the Plan. By accepting this Award, you acknowledge that you are providing the consents herein on a purely voluntary basis and that, if you do not consent or if you later seek to revoke your consent, it will impact the ability of the Company to administer your Awards but it will not adversely impact your employment status or service with your employer.

15. No Contract of Employment or Promise of Future Grants. By accepting this Award, you agree that you are bound by the terms of the Plan and these Terms and Conditions and acknowledge that this Award is granted in the Company’s sole discretion and is not considered part of any employment contract or your ordinary or expected salary or other compensation for services of any kind rendered to the Company or any Subsidiary. You further agree that this Award, and your Plan participation, do not form, and will not be interpreted as forming, an employment contract or guarantee of employment with the Company or any Subsidiary. The Company, in its sole discretion, voluntarily established the Plan and may amend or terminate it at any time pursuant to the terms of the Plan. You understand that the grant of performance-based stock units under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants of any performance-based stock units, or benefits in lieu of performance-based stock units, even if performance-based stock units have been granted repeatedly in the past and that all decisions with respect to future grants will be in the Company’s sole discretion. By accepting this Award, you also acknowledge that this Award and any gains received hereunder are extraordinary items and are not considered part of your salary or compensation for purposes of any pension or retirement benefits or for purposes of calculating any termination, severance, redundancy, resignation, end of service payments, bonuses, long-service awards, life or accident insurance benefits or similar payments. Neither this Award, nor any gains received hereunder, is intended to replace any pension rights or compensation. If the Company or Subsidiary terminates your employment for any reason, you agree that you will not be entitled to damages or compensation for breach of contract, dismissal (in any circumstances, including unfair dismissal) or compensation for any loss of office or otherwise to any sum, Shares, PBUs or other benefits to compensate you for the loss or diminution in value of any actual or prospective rights, benefits or expectation under or in relation to the Plan.
16. Limitations. Nothing in these Terms and Conditions or the Plan grants to you any right to continued employment with the Company or any Subsidiary or to interfere in any way with the Company or Subsidiary’s right to terminate your employment at any time and for any reason, subject to applicable law. Payment of Shares is not secured by a trust, insurance contract or other funding medium, and you do not have any interest in any fund or specific Company or Subsidiary asset by reason of this Award. You have no rights as a stockholder of the Company pursuant to this Award until Shares are actually delivered to you.
17. Entire Agreement and Amendment. These Terms and Conditions, including the Appendix, and the Plan constitute the entire understanding between you and the Company regarding this Award. These Terms and Conditions supersede any prior agreements, commitments or negotiations concerning this Award. These Terms and Conditions may not be modified, altered or changed except by the Committee (or its delegate) in writing and pursuant to the terms of the Plan; provided, however, that the Company has the unilateral authority to amend these Terms and Conditions without your consent to the extent necessary to comply with applicable securities registration or exchange control requirements and to impose additional requirements on this Award or Shares subject to this Award if the Company, in its sole discretion, deems it necessary or advisable for legal or administrative reasons.
18. Severability. The invalidity or unenforceability of any provision of these Terms and Conditions will not affect the validity or enforceability of the other provisions of these Terms and Conditions, which will remain in full force and effect. Moreover, if any provision is found to be excessively broad in duration, scope or covered activity, the provision will be construed so as to be enforceable to the maximum extent compatible with applicable law.
19. Waiver. By accepting this Award, you acknowledge that a waiver by the Company of any breach by you of a provision of these Terms and Conditions shall not operate or be construed as a waiver by the Company of any other provision of these Terms and Conditions or of a subsequent breach.
20. Notices . By accepting this Award, you agree to receive documents, notices and any other communications relating to your participation in the Plan in writing by regular mail to your last known address on file with your employer, the Company or Subsidiary or any outside Plan administrator, or by electronic means, including by e-mail, through an online system maintained by any outside Plan administrator, or by a posting on the Company’s intranet website or on an online system or website maintained by any outside Plan administrator.
21. Governing Law. This Award and these Terms and Conditions are governed by the law of the State of Delaware and shall be construed accordingly.
22. Code Section 409A Compliance. Notwithstanding any other provision of these Terms and Conditions to the contrary, in the event that all or a portion of this Award becomes subject to Code Section 409A, the provisions contained in Section 7.11 of the Plan (entitled “ Section 409A Compliance ”) shall govern and shall supersede any applicable provision of these Terms and Conditions.
23. Acceptance . By accepting this Award, you agree to the following:
(i)      You have carefully read, fully understand and agree to all of the terms and conditions contained in the Plan and these Terms and Conditions, including the Appendix; and
(ii)      You understand and agree that the Plan and these Terms and Conditions, including the Appendix, constitute the entire understanding between you and the Company regarding this Award, and that any prior agreements, commitments or negotiations concerning this Award are replaced and superseded.

APPENDIX
TO
TERMS AND CONDITIONS
OF
PERFORMANCE-BASED STOCK UNIT AWARD
Performance-Based Stock Unit Award Vesting Requirements
FY17-FY19 Performance Period


Performance Goals
This Appendix describes the vesting requirements for performance-based stock units (“PBUs”) awarded under these “Terms and Conditions of Performance-Based Stock Unit Award” for the FY17-FY19 Performance Period (January 1, 2017 through December 31, 2019, which shall be the “Performance Period”). The number of PBUs subject to these Terms and Conditions that vest is based upon the Company’s Adjusted EPS with adjustment, if any, based on the Company’s Total Shareholder Return as compared to the Total Shareholder Return of companies that comprise the Russell 3000 during the Performance Period, as described further below. After the expiration of the Performance Period, the Committee shall calculate the level of achievement attained for the Performance Period in the manner described below and certify the extent to which the performance goals have been achieved. You shall become vested in the number of PBUs that corresponds to the attained level of achievement certified by the Committee on the date that the Committee formally certifies such attained level of achievement (the “Committee Certification Date”). The Committee Certification Date shall occur no later than two and one-half months after the conclusion of the Performance Period. Except as otherwise provided in these Terms and Conditions, if your employment terminates for any reason before the Committee Certification Date, you will automatically forfeit all PBUs and they will be cancelled as of your Termination of Employment date.

Calculation of Preliminary Performance Factor
The Preliminary Performance Factor shall be determined based on the Company’s three-year cumulative Adjusted EPS and shall be calculated in accordance with the following table:

3-Year Cumulative
Adjusted EPS
Performance as a Percentage of EPS Target
Preliminary
Performance Factor
$5.54 and higher
114% or higher (maximum)
200%
$4.86
100% (target)
100%
$4.37
90% (threshold)
50%
Less than $4.37
Less than 90%
0%

The Preliminary Performance Factor is prorated on a straight line basis (i.e., by linear interpolation) for performance that falls between the performance targets set forth in the table above. In no event shall the Preliminary Performance Factor exceed two hundred percent (200%).

For purposes of calculating the Performance Factor, Adjusted EPS means the Company’s diluted earnings per share, adjusted for costs related to restructuring and repositioning expenses and related asset impairments; certain pension costs (net); income and expense items related to divested businesses, product lines and certain other investments; gains and losses on sales of businesses, product lines and certain other investments; certain other unusual or infrequent items that are not representative of underlying trends; and certain other discrete tax items. All of the foregoing shall include the impact of acquisitions or divestitures that are closed during the Performance Period.

Calculation of Total Shareholder Return
Total Shareholder Return during the Performance Period for the Company and for all companies that comprise the Russell 3000 index shall be determined as follows:

Total Shareholder Return = (Change in Stock Price + Dividends Paid) / Beginning Stock Price

“Beginning Stock Price” means the closing price as reported on the applicable stock exchange of one (1) share of common stock on the first trading day of the Performance Period.

“Change in Stock Price” means the difference between the Beginning Stock Price and the Ending Stock Price.

“Dividends Paid” means the total of all dividends paid on one (1) share of stock during the Performance Period. For this purpose, a dividend is paid during the Performance Period if it is actually received by shareholders within the Performance Period, irrespective of when the issuing company declared such dividend.

“Ending Stock Price” means the closing price as reported on the applicable stock exchange of one (1) share of common stock on the last trading day of the Performance Period.

“Performance Period” means the three-year period commencing January 1, 2017 and ending on December 31, 2019.

Example : If the Beginning Stock Price for a company was $50.00 per share, the company paid $5.00 in dividends over the Performance Period and the Ending Stock Price was $55.00 per share (thereby making the Change in Stock Price $5.00 ($55.00 minus $50.00)), then the Total Shareholder Return for that company would be twenty percent (20%). The calculation is as follows: .2 = ($5 + $5) / $50

Calculation of Performance Factor
The Performance Factor is determined by adjusting the Preliminary Performance Factor based on the percentile rank that the Company’s has achieved for Total Shareholder Return as compared to the other companies in the Russell 3000 index; provided, however, that this TSR Modified cannot increase the Performance Factor above two hundred percent (200%). The adjustment is based on the TSR Modifier, as set forth in the following chart:

Company Total Shareholder Return Percentile As Compared to Russell 3000

TSR Modifier
90 th  or above
+
At least 80 th  but not 90 th
+
At least 70 th  but not 80 th  
+
At least 60 th  but not 70 th  
+
At least 40 th  but not 60 th
0%
At least 30 th  but not 40 th  
-10%
At least 20 th  but not 30 th  
-15%
At least 10 th  but not 20 th  
-20%
Below 10 th
-25%






      








Example : For purposes of this example, assume that the Preliminary Performance Factor is 150%. If the Company’s TSR rank is the 75 th percentile, the Performance Factor would be 172.5% (150% + (150 * 15%)). However, if the Company’s TSR rank is the 25 th percentile, the Performance Factor would be 127.5% (150% - (150 * 15%)). Finally, if the Company’s TSR rank was the 50 th percentile, the Performance Factor would remain unchanged at 150%.

Shortly after the expiration of the Performance Period, the Committee shall calculate the level of achievement attained for the Performance Period in the manner described above and certify the Performance Factor. You shall become vested in the number of shares determined by multiplying the total number of PBUs subject to this Award (as set forth in Section 1) by the Performance Factor certified by the Committee on the Committee Certification Date.

Example: For purposes of this example, assume that you were awarded 100 PBUs and that the Committee certified a Performance Factor of 150%. On the Committee Certification Date, you would become vested in 150 shares (100 * 150%).

1 / 1      FY17 PBU Award Certificate
EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Gregory E. Poling, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of GCP Applied Technologies Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2017

 
 
/s/ GREGORY E. POLING
 
 
Gregory E. Poling
President and Chief Executive Officer


Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Dean P. Freeman, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of GCP Applied Technologies Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2017

 
 
/s/ DEAN P. FREEMAN
 
 
Dean P. Freeman
Vice President and Chief Financial Officer



Exhibit 32

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), the undersigned certifies that (1) this Quarterly Report of GCP Applied Technologies Inc. (the "Company") on Form 10-Q for the period ended March 31, 2017 , as filed with the Securities and Exchange Commission on the date hereof (this "Report"), fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ GREGORY E. POLING
 
 
President and Chief Executive Officer
 
 
 
 
 
/s/ DEAN P. FREEMAN
 
 
Vice President and Chief Financial Officer
 
 
Date: May 9, 2017

        A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.